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ABSTRACT 
An abnormal multicellular architecture and a stiffened extracellular matrix (ECM) 
are defining characteristics of breast cancer, and yet, most in vitro tumor models fail to 
recapitulate the aberrant tumor microenvironment or accurately predict in vivo cellular 
responses to therapeutics. This dissertation aims to fill this gap in knowledge by 
developing and applying a suite of novel in vitro tools to investigate how the physical 
properties of the tumor microenvironment drive cancer progression.  
Our approach to develop and apply in vitro tools rests on three independent, but 
synergistic pillars. First, we established a 3D in vitro tumor model that mimics critical 
cell-cell and cell-ECM interactions by embedding multicellular spheroids within 3D 
collagen matrices.  We assessed the in vivo relevance of our 3D collagen embedded 
spheroid model by quantifying the presence of highly malignant cancer stem cells (CSCs) 
before and after chemotherapeutic treatment with either paclitaxel or cisplatin. By 
characterizing the CSC response within two other commonly used in vitro models—a 2D 
monolayer and a 3D collagen model in which single cells are diffusely embedded—we 
  viii 
found the CSC response to be model-dependent. Our results therefore highlight the need 
to screen potential CSC-specific chemotherapy drugs within in vitro models that 
recapitulate the in vivo 3D multicellular tumor architecture.  
Second, through integrating computational and experimental approaches, we 
developed a mathematical model of the transcriptional regulators—Yes-associated 
protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ)—which 
are often overactive in late-stage cancers despite mutations within their upstream 
signaling pathway being rare. Here, dysregulated cytoskeletal tension and disrupted 
apical-basal polarity, two defining characteristics of breast cancer, have been suggested 
to promote overactive YAP/TAZ signaling. Therefore, we developed a computational 
model to study how overactive cytoskeletal tension, due to increased ECM stiffness, 
leads to aberrant YAP/TAZ signaling in cancer. The model revealed that simultaneous 
alterations in cell mechanics and cell-cell adhesion signaling synergistically converge on 
YAP/TAZ activity and lead to its overactivation, a process poorly understood in cancer 
progression.  
Finally, in an effort to decouple the effects of collagen fiber density and network 
mechanics on cancer cell behavior, we developed a highly tunable in vitro 3D 
interpenetrating network (IPN) platform consisting of a primary collagen network 
reinforced by a secondary visible-light-mediated thiol-ene PEG network. The IPN 
platform is cytocompatible, inherently bioactive, and mechanically tunable, which makes 
it a useful tool for studying mechanotransductive signaling pathways. Moreover, while 
this thesis work focused on in vitro applications, our approach raises the interesting 
  ix 
possibility of altering the physical properties of the tumor microenvironment as a 
potential therapeutic.  
In summary, this work addresses the question of how the physical properties of 
the tumor microenvironment affect cancer progression by deploying three distinct, but 
complementary approaches, and suggests that addressing the physical aspects of cancer 
progression may improve clinical outcomes.   
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CHAPTER 1. Introduction 
 Mechanical forces are ubiquitous in biology
1
. From large-scale forces generated 
by the musculoskeletal and cardiovascular systems to nano-scale forces generated by the 
cytoskeleton, these forces are critical in mediating many biological processes such as 
morphogenesis, wound repair, and cancer
1,2
. 
 In healthy tissue, cellular mechanical forces are in a state of stable equilibrium, 
which is referred to as tensional homeostasis
3
. Tensional homeostasis is regulated by 
intercellular tension and the overall tissue architecture. However, in cancer, aberrant 
growth disrupts tensional homeostasis by upregulating intercellular tension and altering 
tissue architecture.  
 Previous efforts have suffered from a lack of robust and quantitative in vitro tools 
that investigate cancer cellular behavior within microenvironments that recapitulate 
critical cell-cell and cell-ECM interactions found in vivo. For example, cancer formation 
and progression have been proposed to be mediated through a small, but highly malignant 
subpopulation of cancer cells possessing stem-like properties, known as cancer stem cells 
(CSCs)
4
. Yet, efforts to screen drugs that are specific to CSCs have mostly only utilized 
2D cell culture platforms
5
, which do not accurately reflect the in vivo tumor 
microenvironment.  
In addition, while previous studies have shown that altered ECM mechanics affect 
cellular behavior through the activation of the mechano-sensitive YAP/TAZ signaling 
pathway
6
, which is also correlated with late-stage and highly malignant cancers
7
; a robust 
mathematical representation of the YAP/TAZ signaling pathway is absent. Such a 
 2 
mathematical model could be used to investigate the key parameters regulating 
YAP/TAZ activity in cancer, and could also lead to the potential discovery of new targets 
for chemotherapy.  
With regards to investigating the effects of ECM properties on cancer 
progression, a 3D in vitro cell culture platform that is both inherently bioactive and 
mechanically tunable is needed. Previous efforts have mostly utilized either naturally-
derived matrices
3,8
, which possess inherent bioactivity, but lack tunable mechanical 
properties, or synthetic polymeric networks
9,10
, which have tunable mechanical 
properties, but lack bioactivity.  
As a result of these gaps in knowledge, this dissertation developed and applied a 
suite of novel in vitro tools to investigate how the physical properties of the tumor 
microenvironment drive cancer progression.  
1.1 Hypothesis and Aims 
 Based on our work and current literature, we hypothesized that physical cues 
within the tumor microenvironment contribute to cancer progression. To that end, we 
built our work upon three Specific Aims: 
Aim 1: Investigation of CSC response to chemotherapeutic treatment as a function of in 
vitro tumor model  
 CSCs are a rare population of cancer cells that are highly tumorigenic, and are 
thought to be the main mediators of tumor formation and propagation. In addition, an 
abnormal multicellular architecture is a defining characteristic of solid cancers. However, 
the effect of this abnormal multicellular architecture on CSC behavior has not been well 
 3 
studied. Previous efforts to study CSC behavior have mostly used 2D cell culture 
systems, which do not recapitulate the key cell-cell and cell-ECM interactions found in 
vivo. Therefore, the observed behavior of CSCs within these 2D cell culture systems may 
not reflect in vivo behavior, which may explain why these studies have not efficiently 
translated to the clinic. The work described in this specific aim established a more 
clinically-relevant in vitro tumor model, composed of a 3D multicellular spheroid 
embedded within 3D collagen gels, and assessed the CSC response to chemotherapeutic 
assault by either paclitaxel or cisplatin.  
Aim 2: Development and experimental validation of a mathematical model of YAP/TAZ 
signaling 
 The YAP/TAZ signaling pathway has been shown to be regulated by external 
mechanical signals and overactivated in late-stage cancers. Furthermore, YAP/TAZ 
signaling has also been shown to be connected to stem-like behavior in cancer cells. 
However, there has yet to be a robust mathematical representation of YAP/TAZ 
signaling. Here, in collaboration with computational biologists, we developed and 
experimentally validated a mathematical model of YAP/TAZ signaling that integrates 
both cell-ECM mechanosensing and cell-cell contact sensing signaling pathways. The 
objective of this work was to understand the critical parameters mediating YAP/TAZ 
dysregulation in cancer.  
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Aim 3: Designing of a 3D in vitro PEG/Collagen interpenetrating network (IPN) for the 
study of 3D mechanotransduction 
Using naturally-derived ECM matrices to study cancer cell behavior within a 3D 
environment is challenged by the inability to independently investigate specific matrix 
parameters such as stiffness, pore size, and fiber density. An alternative strategy is to 
culture cells within synthetic polymeric networks, which are highly tunable, but suffer 
from a lack of cell adhesion sites. To overcome these limitations, we proposed 
developing an interpenetrating network composed of a primary collagen network 
reinforced by a secondary poly(ethylene glycol) (PEG) network. The proposed IPN 
platform combines the inherent bioactivity of collagen with the tunable mechanical 
properties of a synthetic PEG network, and enabled us to decouple ECM mechanical 
properties from collagen fiber density.   
1.2  Structure of Thesis 
 Chapter 2 provides background information on cancer and the physical properties 
of the tumor microenvironment. In addition, the chapter describes the 
mechanotransductive machinery by which cells are able to send and receive mechanical 
signals. The chapter also details the CSC paradigm and its supporting evidence. Finally, 
Chapter 2 concludes with an overview of the YAP/TAZ signaling pathway, its 
involvement in mechanotransduction, and its connection to stem-like behavior. 
 In the following chapters, Chapter 3 reports on our work in which we assessed the 
clinical relevance of our established 3D in vitro spheroid model by quantifying the CSC 
content before and after chemotherapeutic treatment with either paclitaxel or cisplatin. 
 5 
Chapter 4 details the development and experimental validation of a mathematical model 
of the YAP/TAZ signaling pathway. Chapter 5 describes the design and development of 
the PEG/Collagen IPN cell culture platform and its application in studying the effect of 
mechanical confinement on cellular behavior. Finally, the last chapter, Chapter 6, 
summarizes the conclusions of this study and highlights potential directions of future 
work.  
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CHAPTER 2. Background 
In the United States, approximately 600,000 people died from cancer in 2016, 
making it one of the deadliest diseases, second only to heart disease
11
. Moreover, while 
the overall cancer mortality rate in the United States has fallen in the last two decades, 
the mortality rates for some cancer types have remained unchanged or have even 
increased
12
. Furthermore, the World Health Organization predicts that the number of 
worldwide cancer deaths will increase 70% in the next two decades
13
. Therefore, 
understanding and treating cancer is a challenge that will need to be addressed by both 
developed and developing countries well into the 21
st
 century.  
2.1 The Hallmarks of Cancer: 
 Cancer is a complex and diverse disease that represents normal cellular behavior 
gone awry, but despite the varied molecular mechanisms underlying cancer, a common 
set of characteristics has emerged, referred to as the “Hallmarks of Cancer”14,15. These 
hallmarks provide a logical framework by which to understand cancer progression. To 
date, eight hallmarks have been identified: 1) sustained proliferative signaling, 2) evasion 
of growth suppressors, 3) resistance to cell death, 4) replicative immortality, 5) induction 
of angiogenesis, 6) activation of invasion and metastasis, 7) deregulation of cellular 
metabolism, and 8) avoidance of immune destruction (Figure 2-1). In addition, while not 
considered hallmarks in their own right, genomic instability and tumor-promoting 
inflammation are considered enabling characteristics. Ultimately, the acquisition of these 
hallmarks during tumor progression enable normal cells to become tumorigenic and 
subsequently malignant.  
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 Uncontrolled cellular growth is perhaps the most recognized hallmark of cancer, 
and arises from the deregulation of proliferative signaling pathways. Here, sustained 
proliferation can occur through aberrant growth factor signaling, either from the 
upregulation of growth factor ligands by the cancerous cells themselves, in an autocrine-
type manner, or from the stimulation of nearby stromal cells by cancer cells to produce 
growth factor ligands in a paracrine-type manner
16
. Additionally, cancer cells may 
become hyper-sensitive to otherwise normal levels of growth factor ligand through the 
upregulation of growth factor receptors. Growth factors that have been shown to be 
upregulated in cancer include, but are not limited to, epidermal growth factor (EGF)
17
, 
insulin-like growth factor (IGF)
18
, platelet-derived growth factor (PDGF)
19
, hepatocyte 
growth factor (HGF)
20
, and transforming growth factor beta (TGF-β)21–23. Furthermore, 
downstream effectors of growth factor signaling can also become mutated and 
consequently promote chronic proliferation even in the absence of external growth factor 
ligands. Such mutations have been found to be within the mitogen-activated protein 
(MAP)-kinase pathway
24
, phosphoinositide 3-kinase (PI3K)
25
, PTEN
25
, and Ras
26
.  
 While chronic proliferative signaling is analogous to stepping on the gas-pedal in 
a car, evasion of growth suppressors is akin to cutting the brakes. The two prototypical 
tumor suppressors are the RB (retinoblastoma-associated) and TP53 proteins. The RB 
protein is a critical gatekeeper that regulates cell-cycle progression by interpreting 
extracellular growth signals
27
. In contrast, the TP53 protein senses stresses from inside 
the cell, such as excessive genomic damage or diminished nutrient levels, and can halt 
cellular growth if conditions are suboptimal
28
. With both RB or TP53, a defective 
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mutation can lead to chronic proliferation as a consequence of their anti-proliferative 
effects being compromised.  
 In addition to tightly regulating proliferation, normal cells also tightly regulate 
apoptosis, and mutations that enable cells to become more resistant to cell death also 
contribute to cancer progression. Cells regulate apoptosis through two major signaling 
circuits: the first is an extrinsic pathway involving the interpretation of extracellular 
signals via the Fas receptor and Fas ligand, and the second is an intrinsic pathway 
involving the transduction of intracellular signals
29
. In both circuits, activation ultimately 
leads to the initiation of a caspase signaling cascade that ends with apoptosis. The anti-
apoptotic proteins Bcl-2, Bcl-xL, Bcl-w, Mcl-1, and A1 are often upregulated in cancers. 
Furthermore, while apoptosis is a well-controlled cellular program that has very little 
effect on neighboring cells, an additional cell-death program known as necrosis, 
sometimes described as cataclysmic cell-death, causes cells to rupture and release their 
cellular contents into the extracellular space
30
. Included in this release of cellular content 
are pro-inflammatory signals that can recruit inflammatory cells to the tumor site, which 
further promotes cancer progression
31
.  
 Although uncontrolled cell growth is a defining characteristic of cancer, cancer 
cells cannot proliferate indefinitely unless they achieve replicative immortality. Normal 
cells are able to divide only a finite number of times before they undergo either 
senescence, a non-proliferative but viable state, or crisis, a dysfunctional state involving 
cell death. Cellular senescence and crisis are mediated through telomeres, specialized 
DNA segments that protect the ends of chromosomes, which shorten after every cellular 
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division
32
. Ultimately, within normal cells, the telomeres shorten to a point at which they 
can no longer protect chromosomal integrity, and cells undergo senescence or crisis via 
end-to-end fusions of chromosomes. However, cancer cells are able to circumvent the 
shortening of telomeres by expressing telomerase, a specialized DNA polymerase that 
adds telomere repeat segments to the ends of telomeric DNA. This mechanism enables 
cancer cells to proliferate indefinitely, overcoming a major hurdle to tumor progression.  
 Tumors, just as with normal tissue, require the delivery of oxygen and nutrients as 
well as the removal of metabolic waste to remain viable. To this end, tumors can induce 
the formation of their own vasculature through the process known as angiogenesis. Here, 
tumors stimulate the continual sprouting of new blood vessels by activating what is 
referred to the ‘angiogenic switch’, which is associated with the upregulation of vascular 
endothelial growth factor-A (VEGF-A), an inducer of angiogenesis
33
. Furthermore, 
VEGF gene expression can be upregulated by both hypoxia and oncogenic signaling
34
. 
Notably, the vasculature associated with tumors is abnormal and characterized by 
excessive vessel branching, enlarged vessels, erratic blood flow, and leakiness
34
. The 
abnormal properties of tumor-associated vasculature can aid in the dissemination of 
cancer cells, but it also enables passive drug targeting
35
. Moreover, promising efforts 
have been made to normalize the tumor-associated vasculature, which appears to impair 
tumor progression
36
. 
 In cancer, approximately 90% of cancer-related deaths are due not to the primary 
tumor site, but from the formation of secondary tumors at distant sites through the 
process known as metastasis
37
. Metastasis is a multistep process involving the following: 
 10 
1) local invasion away from primary tumors, 2) intravasation into the blood stream, 3) 
extravasation out of the bloodstream and into a secondary tissue, and 4) colonization of 
the secondary site
37
. The physical translocation of cancer cells was initially thought to be 
mainly mediated by the induction of the epithelial-to-mesenchymal transition (EMT), a 
cellular program that is normally activated during embryogenesis to coordinate cellular 
movement, however, recent evidence has shown that cancer cells can migrate without 
undergoing EMT, therefore suggesting that while EMT may aid in migration, it may not 
be a prerequisite for metastasis
38
. Furthermore, EMT was once considered to be a bi-
stable switch between epithelial and mesenchymal phenotypes, but recent evidence has 
suggested that it contains intermediate states
39
. The clinical significance of these 
intermediate states is yet to be determined, but some have argued that they are associated 
with stem-like properties and greater malignancy
40
. Ultimately, the rate-limiting step of 
metastasis is colonization, whereby translocated cancer cells form macroscopic tumors. 
The mechanisms underlying colonization are still not fully understood as most 
translocated cells do not proceed to form macroscopic tumors. To explain the rarity of 
colonization events, the cancer stem cell paradigm has been offered, which holds that 
colonization requires the translocation of a rare cancer cell belonging to a subpopulation 
of tumor cells exhibiting stem-like properties, known as cancer stem cells (CSCs)
41
. The 
CSC paradigm will be further discussed in a subsequent section.  
 Another hallmark of cancer, that until recently was underappreciated, is 
deregulated cellular metabolism. Here, as first observed by Otto Warburg in the early- to 
mid-twentieth century, cancer cells exhibit an unusual form of metabolism whereby they 
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use glycolysis, even in the presence of oxygen
42
. This form of metabolism is now referred 
to as “aerobic glycolysis”, and it is unusual because it is ~18-fold less efficient at 
generating ATP than normal aerobic metabolism. However, the proposed functional 
rationale for the switch to aerobic glycolysis, despite its inefficiency, is that it may allow 
cancer cells to divert glycolytic intermediates toward biosynthetic pathways, such as 
those involved in nucleoside and amino acid production, which may be advantageous for 
continuously proliferating cells
42
.  
 The last hallmark of cancer is evasion of immune destruction. The immune 
system is thought to offer a line of defense against cancer formation as it has the ability to 
identify and eliminate nascent cancer cells. Moreover, recent successes in 
immunotherapy also demonstrate the tumor suppressive effects of the immune system
43
. 
However, as cancers progress, they can evade immune detection by mechanisms such as 
suppressing T cell activity near tumors
44
. Therefore, evading immune destruction has 
become recognized as an additional hallmark of cancer.  
2.2 Overview of Breast Cancer 
Breast cancer is the most common form of cancer for women in the United States, 
with approximately 250,000 new cases expected to be diagnosed in 2017, and 
approximately 40,000 deaths
45
. Breast cancer encompasses a diverse collection of tumors 
with characteristic molecular features, prognosis, and responses to therapy
46
. In general, 
breast cancers are classified into five subtypes according to gene expression signatures: 
luminal A, luminal B, Her2-enriched (also known as ERBB2), basal-like, and normal-
like
47
. 
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Luminal subtypes display luminal epithelial markers, frequently express estrogen 
and progesterone receptors, and often have better prognoses with fewer metastases
47
. The 
Her2-enriched subtype is defined by overexpression of ERBB2, often resulting from copy 
number alterations, and is associated with poor prognoses and distant metastases. Basal-
like, also referred to as triple negative breast cancer because it lacks the expression of 
estrogen and progesterone receptors as well as ERBB2 expression, has a gene expression 
signature similar to basal epithelial cells and is strongly correlated with mutations in the 
BRCA1 gene. Furthermore, the basal-like subtype has been linked to an embryonic stem 
cell gene expression signature
48
 and has the poorest prognoses. The normal-like breast 
cancer subtype is similar to luminal A, but more resembles the normal mammary profile 
and has slightly worse prognoses
49
.  
Importantly, breast cancer subtypes have differing responses to chemotherapy, 
and classifying a given breast cancer can lead to better treatment strategies. For example, 
with the luminal subtypes, which express progesterone and estrogen receptors, hormonal 
therapies have been shown to be effective
50
. For the Her2 subtype, the overexpressed 
Her2 receptor can be targeted, such as is the case with trastuzumab therapy
51
. However, 
with the basal-like subtype, due to the lack of hormone receptors or the Her2 receptor, 
conventional chemotherapy is still the most common form of treatment administered
49
. 
2.3 The Breast Cancer Tumor Microenvironment 
 Although cancer has long been considered to progress through a sequence of 
genomic mutations that lead to the acquisition of the aforementioned hallmarks, cancer 
progression is more than just changes within the cancer cells themselves as changes in the 
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tumor microenvironment also play a critical role in tumor development, as shown in 
Figure 2-2
52,53
. For example, stromal cells, such as fibroblasts
54
 and immune cells
55
, assist 
cancer at various stages of tumor development and dissemination. In addition, these 
stromal cells can work in concert with cancer cells to actively modify the physical 
properties of the extracellular matrix (ECM)
56
, which further contributes to tumor 
progression. Therefore, while cancer research has traditionally focused on biochemical 
mechanisms, recent studies have now begun to investigate how the abnormal physical 
properties of the tumor microenvironment also drive cancer progression. 
To fully appreciate how abnormal cancerous mammary tissue affects tumor 
progression, it is important to first understand the structure of the normal mammary gland 
and how its structure regulates its function. The normal mammary gland is composed of a 
branching ductal network terminated by lobules at the distal ends. The hollow lumen 
within these branching networks is surrounded by mammary epithelium, which is 
organized into two distinct compartments: 1) an inner luminal compartment and 2) an 
outer basal compartment. The inner luminal compartment is composed of luminal 
epithelial cells that differentiate into milk-producing alveoli during lactation, while the 
basal compartment is made up of basal myoepithelial cells that contract and push milk 
through the ducts in response to hormone signaling
57,58
. The mammary epithelium is 
enveloped by a basement membrane comprised mostly of collagen IV and laminin-111, 
which is itself surrounded by the mammary fat pad
59
. Importantly, the aforementioned 
structure of the mammary gland is integral to its function by maintaining spatially 
patterned regions of intercellular tension and soluble cytokine signals
57
. 
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 At the onset of tumor formation, uncontrolled growth leads to disruption of 
normal multicellular architecture, which is followed by extensive ECM remodeling and 
stiffening. In fact, the stiffness of the mammary tissue can increase by over 20-fold: from 
200 Pa in healthy mammary tissue to over 4 kPa in tumor-associated tissue
3
. Notably, a 
clinical study from 15 years ago discovered that patients with stiff fibrotic lesions have 
poorer prognoses
60
, but at the time it was unclear how ECM stiffening was linked to 
tumor progression.  
 Subsequent investigations into the molecular connection between tissue stiffening 
and tumor progression revealed that ECM stiffening—caused by tumor-associated ECM 
remodeling and characterized by increased ECM deposition, fiber alignment, and 
crosslinking—alters cellular behavior and promotes the malignant phenotype through 
altered integrin signaling
3,61
, increased focal adhesion formation
61
, elevated Rho-
dependent cytoskeletal tension
62,63
, disruption of adherens junctions
64
, and loss of tissue 
polarity
65
, as shown in Figure 2-3. Moreover, inhibiting the enzymatic activity of lysyl-
oxidase (LOX), an enzyme that covalently crosslinks the ECM proteins collagen and 
elastin, led to softer tumor microenvironments, and more importantly, better prognoses 
within a mouse animal model
61
. Conversely, in a separate study, normal mammary 
epithelial cells were shown to be driven towards a malignant phenotype by increased 
matrix stiffness alone
66
. These findings illustrate the manner in which cancer cells can 
sense and manipulate their own microenvironment to promote tumor growth.  
 Cell migration is also affected by the physical properties of the ECM. For instance, 
key parameters in cell migration, such as cell speed, are crucially affected by matrix 
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stiffness
67
. ECM properties also affect directional motility, as cells have long been shown 
to preferentially migrate along 2D substrates from softer to stiffer environments in a 
process known as durotaxis
68
. While such behavior was reproduced when the 2D 
substrate was overlain with a 3D collagen matrix
69
, recently developed approaches 
capable of generating 3D ECM stiffness gradients have revealed that cells, in some cases, 
are able to migrate from stiff to soft matrices in a process called ‘reverse durotaxis’70,71. 
 In addition to stiffness, the ECM architecture itself can direct migratory behavior. 
For example, collagen fiber alignment is correlated with advanced progression, since 
alignment of fibers away from the tumor enables cancer cells to migrate persistently 
along those fibers
72
. Furthermore, the higher mechanical resistance associated with 
increased ECM density has recently been shown to cause a shift to protease-dependent 
invasion
73
, whereby ECM fibers are degraded by matrix metalloproteinases (MMPs). 
However, if MMPs are inhibited, cancer cells can switch to an MMP-independent mode 
of migration
74
. Therefore, the ECM properties have a profound effect on cell migratory 
behavior and metastases.  
 The abnormal multicellular architecture can also cause spatial gradients in oxygen 
tension with regions of cells being subjected to hypoxic conditions. These regions of 
hypoxia can drive cancer progression as hypoxia has been shown to stimulate the 
epithelial-to-mesenchymal transition (EMT), and consequently cancer cell migration, 
through Notch signaling and Snail-1 upregulation
75
. Snail-1 activity is increased by two 
distinct, but synergistic, Notch-mediated mechanisms: 1) the intracellular domain of 
Notch binds to the Snail-1 promoter and consequently increases its expression, and 2) 
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Notch mediates the recruitment of hypoxia-inducible factor 1α (HIF-1α) to the LOX 
promoter, thereby elevating LOX expression, which in addition to its role in crosslinking 
ECM molecules, stabilizes the Snail-1 protein. Furthermore, hypoxia can also lead to 
increases in collagen deposition and MMP production
76
. Therefore, hypoxia-driven ECM 
remodeling may also reinforce cancer cell migration by promoting an invasive 
phenotype
76,77
. 
2.4 Mechanotransduction and Tensional Homeostasis 
 The way in which cells sense the physical properties of their microenvironment is 
through mechanotransduction. In general, mechanotransduction is the process by which 
cells convert mechanical signals from their microenvironment into biochemical signals 
for directed cellular behavior
1
. Importantly, this process is bi-directional as cells are able 
to both exert their own cell-generated forces (inside-out) and respond to external forces 
from the ECM and neighboring cells (outside-in). This dynamic interplay is involved in 
regulating several key cellular processes including morphogenesis
78
, cell migration
79,80
, 
proliferation
81,82
, differentiation
83–88
, and apoptosis
89
. 
 Cells adhere to their surrounding ECM through integrins, a family of 
heterodimeric transmembrane proteins comprised of 18 α-subunits and 8 β-subunits to 
form 24 unique constructs
90
. Importantly, integrins serve as the main mediators of cell-
ECM mechanotransduction and link extracellular and intracellular mechanical cues. 
Upon activation, integrins cluster to form nascent adhesions, which are highly organized 
protein assemblies composed of focal adhesion kinase (FAK), paxillin, talin, vinculin, 
zyxin, vasodilator stimulating phosphoprotein (VASP), and α-actinin, as shown in Figure 
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2-4. These nascent adhesions either turnover rapidly or mature into larger focal 
complexes and even larger focal adhesions
1
. This process of focal adhesion formation has 
been shown to be mediated by the presence of mechanical forces as several protein 
domains within talin, paxillin, and p130cas unfold and expose cryptic binding and/or 
phosphorylation sites in the presence of applied forces
1,91
. 
 These focal complexes and adhesions connect to the cytoskeleton through 
interactions with filamentous actin (F-actin). F-actin, together with myosin, serve as the 
cell contractile apparatus, which provides cells with mechanical integrity and the ability 
to exert forces on their surroundings. The cytoskeleton is regulated by Rho family 
GTPases, which are organized into three subgroups: RhoA, Rac1, and Cdc42
92
. In 
general, Rho GTPases are targeted to cell membranes and cycle between GTP- and GDP-
bound states. In the absence of an upstream stimulus, Rho proteins are in an inactive 
GDP-bound state. However, upon activation by growth factor receptors and integrins, 
Rho proteins exchange GDP for GTP via Rho guanine nucleotide exchange factors (Rho-
GEFs) and interact with a range of downstream effector proteins, such as Rho kinase 
(ROCK) and p21-activated kinase (PAK), that ultimately alter cellular behavior. Rho 
proteins return to an inactive GDP-bound state via GTP hydrolysis by Rho-GTPase 
activating proteins (Rho-GAPs). 
 In cancer, overexpression of Rho proteins have been observed in a number of 
cancer types including breast
62,93–95
, colon
62
, lung
62
, head and neck
62
, and pancreatic
96
. 
Rho protein overexpression increases cytoskeletal tension, which leads to aberrant 
cellular behavior such as chronic proliferation, resistance to apoptosis, and migration
62
. In 
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addition, evidence has shown that high rates of GDP-GTP cycling are linked to malignant 
transformation, which may be reflective of the cyclical nature of the processes that are 
regulated by Rho proteins during tumorigenesis
92
.  
 In addition to interacting with the ECM, cells also mechanically interact with 
neighboring cells as part of a larger cellular collective. To this end, adherens junctions 
(AJs) serve as the primary element responsible for transducing mechanical forces 
between cells as they link the cytoskeletons of neighboring cells via cadherins
1
, as shown 
in Figure 2-5. Moreover, multicellular architecture (i.e. the geometric shape of cell 
clusters) can lead to spatial patterns of intercellular tension within cellular collectives 
having uniform contractility
79
. Altogether, these mechanotransductive elements can 
become dysregulated within diseased tissues and can actually drive disease progression
3
. 
2.5 The Cancer Stem Cell Paradigm 
 The cancer stem cell (CSC) paradigm holds that tumors are likely initiated and 
subsequently propagated by a highly malignant subpopulation of tumor cells with stem-
like properties, commonly referred to as the CSC subpopulation
97
. The high malignancy 
of CSCs arises from their stem cell-defining capacity for self-renewal and differentiation, 
which, respectively, enable CSCs to propagate indefinitely and generate the more-
differentiated parenchymal cells of the tumor (Figure 2-6). Evidence supporting this 
theory was first uncovered within acute myelogenous leukemia, where it was 
demonstrated that a subset of leukemia cells expressed cellular markers similar to normal 
hematopoietic stem cells
98–100
. Since then, evidence for CSCs have been found within 
solid tumors of many other tissues including the brain
101
, pancreas
102
, colon
103
, and 
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breast
97
. 
 From a clinical perspective, the CSC paradigm has several important implications 
for administering effective treatments and increasing patient survival. First, radio- and 
chemotherapies have been shown to be ineffective against CSCs because they can evade 
these treatments through slower cell-cycling
104
, expression of drug-efflux transporters
105
, 
and upregulation of anti-apoptotic proteins
106
. Moreover, conventional therapeutics may 
actually enrich for CSCs by eliminating the more-differentiated tumor cells. If viewed 
through the lens of Darwin’s theory of natural selection, conventional therapeutics may 
actually increase CSC ‘fitness’ by removing their more-differentiated competitors. 
Therefore, to better combat tumor growth and metastasis, it is imperative to understand 
the underlying biochemical and biophysical mechanisms responsible for CSC self-
renewal, proliferation, and/or induction.  
 The first evidence supporting the presence of stem-like cells within breast cancer 
was discovered over 15 years ago
97
. In the seminal work by al-Hajj et al., the tumor 
forming ability of patient-derived breast cancer cells was examined by xenografting 
breast cancer cells into immunocompromised mice at increasingly dilute cell 
concentrations. The authors discovered that tumor formation required injecting a large 
number of cancer cells, implying that either 1) all injected cancer cells are homogeneous, 
but have low tumorigenic ability, or 2) a rare subpopulation of cancer cells exists with 
high tumorigenic ability. To resolve this, the authors subsequently sorted the breast 
cancer cells into phenotypically distinct subpopulations and found that a specific 
subpopulation expressing the CD44
+
/CD24
-
/EpCAM
+
 phenotype formed tumors more 
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efficiently than the original unsorted population. This therefore suggested that a rare 
subpopulation of highly tumorigenic cancer cells exists within tumors.  
 A connection between aggressive cancers and stem-like properties was revealed 
by performing bioinformatical analyses of breast cancer patient datasets
48,107
. In the clinic, 
the differentiation level (or grade) of tumors is routinely evaluated with poorly 
differentiated (high grade) tumors having the poorest prognoses. These classifications are 
based solely on histopathological criteria, but bioinformatical analysis of breast cancer 
patient datasets revealed that an embryonic stem cell (ESC) signature correlated with 
high-grade estrogen receptor (ER)-negative tumors
48
. This correlation suggests that the 
expression of stem cell-associated factors with specific oncogenes could induce a non-
differentiated state in cancer cells. Moreover, these results are consistent with other 
findings that key regulators of normal ESC identity—OCT4, SOX2, NANOG, and MYC—
are expressed in specific human cancer types
108–112
. 
 The ESC gene expression is also correlated with the basal-like breast cancer 
subtype as basal-like tumors express elevated levels of ESC-associated genes—
specifically OCT4, SOX2, and NANOG targets. This is in agreement with basal-like 
tumors being typically categorized as grade 3, lacking ER expression, exhibiting high 
proliferation rates and having a high nucleus-to-cytoplasm volume ratio
113,114
. In contrast, 
the other breast cancer subtypes—normal-like, luminal type A, luminal type B, and 
HER2-like—did not display an ESC gene expression signature, which is also in 
agreement with these subtypes typically having lower tumor grades and better patient 
prognoses. Taken together, these results illustrate the potentially strong connection 
 21 
between aggressive, highly-malignant cancers and stem-like properties.  
2.6 Mechanotransduction in Normal Stem Cells and Cancer Stem Cells 
 Given the ubiquitous presence of mechanical forces during development, a 
number of studies have begun to investigate whether mechanical cues regulate stem cell 
behavior. Indeed, seminal work revealed that mechanical cues affect the lineage 
commitment of mesenchymal stem cells as constrained and unconstrained cells 
differentiated into adipocytes and osteoblasts, respectively
83
. This switch in lineage 
commitment was found to be mediated by RhoA-ROCK-dependent cytoskeletal tension
83
. 
Moreover, in another study, mesenchymal stem cell lineage commitment was revealed to 
be dependent upon ECM elasticity, further providing evidence that mechanical cues 
affect stem cell behavior
84
.  
 Additionally, the self-renewal and proliferation behavior of hematopoietic stem 
cells
115
 and embryonic stem cells
116
 were found to be enhanced within soft, but not stiff 
substrates. In accordance with these findings, another set of studies found that addition of 
the ROCK inhibitor Y27632, which reduces cytoskeletal tension, increase the survival 
and self-renewal of freshly dissociated ESCs in culture
117–119
. However, interestingly, in a 
later study in which ESCs were cultured as multicellular aggregates, inhibition of ROCK 
by Y27632 led to a decrease in survival and self-renewal
120
. The authors found that Rho 
signaling was critical for the long-term survival of ESCs, and demonstrated that ESC 
mechanotransductive machinery is context-dependent. 
 However, these findings are only a part of a bigger picture, and it should be noted 
that the definition of a stem cell is broad and encompasses a large constituency of cell 
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types ranging from pluripotent embryonic stem cells to bipotent, and even unipotent, 
adult stem cells—all of which reside in different microenvironments with distinct 
mechanical cues. Furthermore, it appears that stem-like properties can be regulated by 
multiple signaling pathways even within the same cell type depending on 
microenvironmental conditions. In keratinocytes, for example, physically constraining 
the cells on micropatterned glass substrates caused the keratinocytes to differentiate via 
serum response factor (SRF) signaling
87
. However, in a later study in which the same 
keratinocytes were cultured on acrylamide substrates instead of glass, unspread cells 
differentiated through integrin-mediated MAPK signaling, not SRF signaling. Therefore, 
these results highlight the importance of mechanical cues in regulating self-renewal and 
proliferation, even within the same cell type.  
 With regards to the mechanotransductive signaling in CSCs, there have been a 
few preliminary studies investigating the role of mechanical cues and 
mechanotransductive elements on CSC behavior. In a study utilizing transgenic mice, 
deletion of FAK within the mammary epithelium delayed tumor initiation and resulted in 
fewer micrometastases to the lung
121
. Importantly, immunofluorescent staining and 
ALDEFLUOR analysis revealed a decrease in CSCs upon deletion of FAK
121
. 
Additionally, in a separate study, deletion of FAK in squamous cell carcinomas also led 
to a decrease in CSCs
122
. These findings therefore implicate the potential role of 
mechanotransductive elements in maintaining and/or inducing CSC behavior.  
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2.7 YAP/TAZ Signaling Pathway 
 The Yorkie-homologues Yes-associated protein (YAP) and transcriptional 
coactivator with PDZ-binding motif (TAZ) have recently been shown to act as nuclear 
relays of mechanical signals
6,123
, as illustrated in Figure 2-7. The YAP/TAZ signaling 
pathway has been shown to initiate cellular proliferation downstream of cytoskeletal 
tension as overexpression of YAP rescues proliferation in physically-constrained cells
6,123
.  
In cancer, bioinformatical analyses of clinical data have shown that the 
upregulation of YAP/TAZ-related genes is correlated with poorly differentiated and 
aggressive Grade 3 tumors when compared to more differentiated Grade 1 tumors
7
. 
Interestingly, ectopic expression of TAZ promotes the formation of high-grade tumors 
and increases the CSC-enriched CD44
+
/CD24
-
 subpopulation within breast cancer cell 
lines
7
. However, despite the apparent role of YAP/TAZ in cancer, mutations within the 
Hippo pathway are actually rare, and thus either we lack an understanding of the core 
mutations within the YAP/TAZ signaling pathway that contribute to cancer and CSC 
behavior, or YAP/TAZ signaling is non-genetically altered in transformed cells. This 
therefore raises the intriguing question of whether the abnormal tumor architecture that is 
associated with high grade tumors activates YAP/TAZ signaling, and consequently, 
promotes CSC behavior. Therefore, these findings motivate the need to quantitatively 
understand the mechano-chemical regulators of CSC fate, form, and function.  
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Figure 2-1: The Hallmarks of Cancer 
The hallmarks of cancer are shown as well as therapeutic strategies targeting each 
hallmark. The hallmarks represent a collection of traits that cancer cells acquire during 
cancer progression that ultimately lead to malignancy. Figure taken from Hanahan and 
Weinberg (2011)
42
. 
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Figure 2-2: The Tumor Microenvironment 
The behavior of cancer cells is largely influenced by their microenvironment. Hypoxia 
can induce the epithelial-to-mesenchymal transition (EMT), stromal cells can release 
chemotactic growth factors, and cell-induced mechanical strains can realign ECM fibers. 
Moreover, these factors have been implicated with tumor progression, invasion, and 
metastasis. Furthermore, cells mediate considerable crosstalk between environmental 
factors. For instance, in response to hypoxia, cells can stiffen the matrix through 
increased LOX expression. Additionally, tumor cells interact with fibroblasts causing the 
deposition of new ECM molecules, and physical forces from strains are associated with 
fiber alignment, leading to persistent migration and tissue invasion of cancer cells. Figure 
taken from Reynolds et al. (2016)
53
.   
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The abnormal tumor microenvironment can actively promote tumor progression through 
dysregulating cytoskeletal tension and proliferation pathways via ECM stiffening and 
focal adhesion formation. Figure taken from Jaalouk and Lammerding (2009)
124
.   
Figure 2-3: Aberrant Mechanotransduction in Cancer Cells 
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Increasing substrate stiffness promotes the formation of focal adhesions from nascent 
adhesions. Focal adhesions are highly organized protein assemblies composed of 
integrins, FAK, paxillin, talin, vinculin, zyxin, and VASP proteins that connect to the 
cytoskeleton. Figure taken from Eyckmans et al. (2011)
1
. 
  
Figure 2-4: The Mechanotransductive Machinery Involved in Cell-ECM 
Interactions. 
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Cells exert mechanical forces between themselves (i.e. intercellular forces) and these 
forces direct cellular behavior. The primary element responsible for mediating 
mechanical forces between cells is the adherens junction as it connects the cytoskeletons 
of adjacent cells via cadherins. Figure taken Eyckmans et al. (2011)
1
. 
  
Figure 2-5: The Mechanotransductive Machinery Involved in Cell-Cell 
Interactions. 
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Figure 2-6: The Cancer Stem Cell Paradigm 
The cancer stem cell (CSC) paradigm holds that tumors have a heterogeneous and 
hierarchical cell population with CSCs at their apex. CSCs are a small, but highly 
malignant subpopulation of cancer cells that can both self-renew and generate the more-
differentiated bulk tumor cell population.  
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Figure 2-7: The Transcription Factors YAP and TAZ Transduce Mechanical 
Signals in Biochemical Signals to Direct Cellular Behavior 
The transcription factors YAP and TAZ are key mediators of mechanical signaling and 
have been shown to regulate a number of cellular behaviors including proliferation, 
apoptosis, and stem cell differentiation. Figure taken from Piccolo et al. (2014)
125
.  
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CHAPTER 3. Investigation of CSC Response to Chemotherapeutic Treatment as a 
Function of In Vitro Tumor Model 
 
3.1 Introduction 
 The cancer stem cell (CSCs) paradigm posits that a small, but highly malignant, 
subpopulation of cancer cells possesses stem-like properties. Moreover, because of their 
stem-like properties, CSCs are thought to have the capacity to reform and propagate 
tumors following therapy, which ultimately lead to patient relapse. Therefore, eradicating 
this highly malignant subpopulation is thought to be critical for improving patient 
outcomes. However, CSCs have been shown to be resistant to conventional radio- and 
chemotherapies
126
. Consequently, several efforts have been made to identify compounds 
specific against the CSC subpopulation, but these efforts have solely relied on initially 
screening drugs within 2D cell culture systems that do not accurately represent the in vivo 
tumor microenvironment
5,127
. The lack of robust and scalable in vitro models that 
recapitulate key aspects of the in vivo tumor microenvironment, such as cell-cell and cell-
ECM interactions, may be one reason why drugs targeting CSCs have not efficiently 
translated to the clinic
126
. To this end, we investigated the response of CSCs to 
chemotherapeutic assault within three distinct in vitro tumor models. 
3.2 Quantifying CSC Content within Untreated In Vitro Tumor Models 
In this investigation, the CSC content was quantified within three distinct in vitro 
tumor models: a) a 2D monolayer, b) a 3D collagen model in which a single cell type is 
diffusely embedded (termed ‘3D diffuse’), and c) a 3D collagen-embedded multicellular 
spheroid model (termed ‘3D embedded spheroid’) (Figure 3-1a-c). 
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The 2D monolayer model represents traditional cell culture methods that  
geometrically constrain cells, force an artificially imposed basal lateral attachment, and 
result in the upregulation of cell cycling and metabolism
128,129
. The 3D diffuse model 
improves upon the 2D monolayer model by recapitulating the three-dimensional cell-
ECM interactions present in vivo, but does not possess key cell-cell interactions present 
within tumors. Therefore, to overcome the inherent limitations of the 3D diffuse model, 
we utilized 3D multicellular spheroids, which mimic important microenvironmental 
characteristics observed within tumors in vivo. These multicellular spheroids are 
hundreds of micrometers in diameter, possess cell-cell contacts, a necrotic core, and 
gradients of proliferation
130,131
. Furthermore, by embedding within 3D collagen, 
multicellular spheroids reside within an ECM similar to that found in vivo, providing 
additional signaling and mechanical cues
132
. Thus, the embedded spheroid model 
described herein more closely recapitulates the native 3D tumor microenvironment than 
conventional 2D culture, facilitating the study of tumor cell behavior within a more 
physiologically relevant context. 
To quantify CSCs, we employed the commercially-available ALDEFLUOR assay, 
which identifies CSCs based on the enzymatic activity of the stem cell marker aldehyde 
dehydrogenase (ALDH)
103,133–136
. ALDH is an intracellular detoxifying enzyme 
previously shown to have a clear functional role in early stage stem cell differentiation 
through its metabolism of retinal to retinoic acid
137
. This assay is consistent across 
cancers of differing tissues and has been used to identify CSCs within a number of 
cancers including leukemia
138
, breast
133
, brain
139
, and colon cancer
140
. We chose the 
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ALDEFLUOR assay over other CSC identification techniques, such as immunological 
surface markers
97
 and Hoescht 33342 dye-exclusion assays
105
, because of the functional 
significance of ALDH in regulating stem-like behavior.  
The limitation of using immunological surface markers is that they often do not 
appear to play a functional role in regulating stem-like behavior, and therefore are often 
inconsistent across cancers of differing tissues. For example, CD24
-
 is a CSC marker in 
breast cancer
97,141
, but CD24
+
 is a CSC marker in pancreatic cancers
142
. This should not 
detract from the scientific findings that have been made with these markers, but it does 
highlight the apparent disconnect between them and actually mediating stem-like 
behavior. With respect to the Hoechst 33342 dye-exclusion assays, stem-like cells are 
identified based on their proposed ability efflux the dye via ABC transporters. Therefore, 
stem-like cells appear as a distinct dim population—the ‘side population’—when 
inspected with a flow cytometer. However, this technique is confounded by variations in 
metabolism and is not directly linked to stem-like behavior.   
In addition to the ALDEFLUOR assay, we used the mammosphere assay to 
quantify stem-like cells
135,143,144
. Here, cells are cultured on low adherent plates and the 
number of clonal growths are measured. This method has been adapted from the normal 
stem cell field and is used to assess stemness in vitro for two reason: 1) stem-like cells 
are intrinsically more resistant to anoikis, a form of programmed cell death that occurs in 
anchorage-dependent cells when they cannot adhere to a substrate, and 2) low adherence 
avoids attachment-induced differentiation in some stem cell types
145,146
. 
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3.2.1 Materials and Methods 
Cell Culture.  The post-metastatic, triple-negative breast cancer cell line MDA.MB.231 
and the post-metastatic, luminal breast cancer cell line MCF7 were purchased from 
American Type Culture Collection (ATCC) and cultured prior to experiments on tissue-
treated polystyrene. The MDA.MB.231 cells were cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin solution for all in vitro models. The MCF7 cells were cultured in 
Eagle’s Minimum Essential Media (EMEM) supplemented with 10% FBS and 1% 
glutamine/penicillin/streptomycin. All experiments were performed at 37
o
C in a 
humidified atmosphere containing CO2. 
In Vitro Tumor Models.  For the 2D monolayer in vitro model, cells continued to be 
cultured on tissue-treated polystyrene as previously mentioned.  For the 3D collagen 
models, High Concentration Rat Tail Type I Collagen (BD Biosciences) was combined 
1:1 with a buffer solution (100 mM HEPES in 2x PBS, pH 7.3), and diluted with PBS to 
a final working concentration. The collagen mixture self-polymerizes into a 3D gel after 
1 hr at 37
o
C. In the single-cell 3D diffusely embedded model, cells were embedded 
within 4 mg/mL collagen gels at a seeding density of 1 x 10
5
 cells/mL
147
. For the 
embedded spheroid model, spheroids composed of 1 x 10
4
 cells were formed by first 
culturing cells on 1.5% (wt/vol) agarose-coated plates for 3 days with the addition of 2.5% 
(vol/vol) of Matrigel (Corning)
148
. After 3 days on agarose, the cells aggregated into 
dense three-dimensional multicellular spheroids, which were then embedded by pipette 
into unpolymerized 4 mg/mL collagen
149
.  
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Extraction of Cells from In Vitro Models.  Upon completion of each experiment, cells in 
the 2D monolayer were harvested using 0.05% trypsin and 0.02% EDTA (Sigma-
Aldrich). For the 3D collagen models, Collagenase Type I (Invitrogen) was used at a 
concentration of 1.5 mg/mL in 1x PBS to dissociated the collagen gels. Additionally, for 
the embedded spheroid condition, collagenase treatment was used to isolate the periphery 
population from the intact spheroid core (Figure 3-2). To disaggregate the intact core, an 
additional treatment of 0.05% trypsin and 0.02% EDTA was performed.  
ALDEFLUOR Assay.  To quantify the CSC population within the aforementioned in vitro 
models, the ALDEFLUOR Stem Cell Identification and Isolation Kit (Stem Cell 
Technologies) was used in conjunction with a BD LSRFortessa (BD Biosciences) flow 
cytometer. Here, cells were incubated in ALDEFLUOR assay buffer containing ALDH 
substrate (1 µM) at a concentration of 5 x 10
5
 cell per mL for 30 minutes at 37
o
C.  For 
each experiment, a corresponding sample of cells was stained under identical conditions 
with 50 mM diethylamineobenzaldehyde (DEAB), a specific ALDH inhibitor as a 
negative control. Propidium iodide (Abcam) was used to identify viable cells, and sorting 
gates were established based on the DEAB-treated negative control. 
Mammosphere Assay.  The mammosphere assay was performed by culturing cells 
isolated from the in vitro models on 24-well ultra-low adherence plates (Corning) in 
mammosphere growth media; which is composed of serum-free mammary epithelial 
growth medium (MEGM) bullet kit (Lonza), without addition of pituitary extract,  and 
supplemented with B27 minus Vitamin A (Invitrogen), 20 ng/mL epidermal growth 
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factor (EGF) and 20 ng/mL basic fibroblast growth factor (bFGF) (BD Biosciences), 4 
µg/mL heparin (Stem Cell Technologies). Cells were seeded at 1 x 10
3
 cells per well and 
half volumes of media were added every 3 days.  After 10 days, brightfield images were 
acquired. Mammospheres were identified as multicellular aggregates larger than 70 µm 
in diameter and counted using ImageJ and a custom-written macro script.  
Gene Expression Analysis.  Cell lysis and initial RNA extraction were performed using 
TRIzol Reagent (ThermoFisher) following manufacturer-recommended procedures. For 
the spheroid models, 18 spheroids were pooled for each replicate. After phase separation, 
RNA extraction was continued using an RNeasy Mini Kit (QIAGEN) with on-column 
DNase I treatment (QIAGEN), and RNA-to-cDNA was executed using the TaqMan 
High-Capacity RNA-to-cDNA Kit (Applied Biosystems). Gene expression was then 
assessed using the TaqMan Gene Expression Assay (Applied Biosystems) and a 
StepOnePlus RT-qPCR System (ThermoFisher).  
Microscopy.  Images were acquired on a DMI600B microscope (Leica) with an ImagEM 
EM-CCD Camera (Hamamatsu Photonics, Hamamatsu, Japan) in a spinning disc 
confocal setup (Yokogawa). Imaging was done using Micro-Manager 1.4 Software 
(http://www.micro-manager.org). Assembling of frames into a single image was 
performed in ImageJ. 
3.2.2 Results 
 For the MDA.MB.231 cell line, the ALDEFLUOR results showed that the 3D 
diffuse model had significantly fewer ALDH
+
 cells than either the 2D monolayer or the 
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3D embedded spheroid models (Figure 3-3a).  Isolation and characterization of the core 
versus periphery populations in the 3D embedded spheroid models revealed that the 
ALDH
+
 cells were preferentially located in the core population at an approximately 2:1 
ratio (Figure 3-3b). Furthermore, these results were further corroborated by the 
mammosphere assay as a similar trend was found with a ratio of CSCs in the core versus 
periphery population being slightly above 5:1. (Figure 3-3c). 
These results were also confirmed via RT-qPCR analysis of ALDH1A3 expression 
as the 3D diffuse condition had significantly less ALDH1A3 expression than the 2D 
monolayer (0.70-fold, p<0.01) (Figure 3-3d). Moreover, ALDH1A3 expression was 
significantly upregulated in the spheroid core population (24-fold, p<0.001) and 
periphery population (11-fold, p<0.001) than the 2D monolayer condition (Figure 3-3d). 
The expression of embryonic stem cell-related genes SOX2, OCT4, and NANOG were 
also found to be upregulated in both the spheroid core and spheroid periphery populations 
compared to the 2D monolayer. For the 3D diffuse condition, SOX2 showed a significant 
upregulation in expression compared to the 2D monolayer (48-fold, p<0.001) while 
NANOG exhibited a modest, but not significant increase and OCT4 showed no change in 
expression. The list of TaqMan probes used in this study is shown in Table 3-1, and the 
fold-change relative to the 2D monolayer for each gene is shown in Table 3-2.  
Taken together, these results suggest that the 3D multicellular architecture of the 
3D spheroid model enriches for the CSC subpopulation, which may better represent the 
cellular heterogeneity present in vivo than conventional 2D monolayer or even 3D diffuse 
models. 
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3.3 Quantifying CSC Content Following Chemotherapeutic Treatment 
 Selective enrichment and failure to eradicate the highly malignant CSC 
subpopulation within in vivo tumors is thought to be a significant driver of cancer relapse, 
particularly following cytotoxic chemotherapy
106
. Therefore, it has been hypothesized 
that a new class of CSC-specific therapies are needed to target this highly malignant 
subpopulation and improve patient outcomes
5,106,150
. To this end, several efforts have 
been made to identify CSC-specific compounds, but their screening methods have only 
used 2D culture systems that do not recapitulate key physical properties of the tumor 
microenvironment
5,151,152
. Therefore, we sought to determine the clinical-relevance of our 
three in vitro tumor models by investigating the response of the CSC subpopulation to 
treatment with two front-line chemotherapy drugs: paclitaxel and cisplatin. 
3.3.1 Materials and Methods 
Chemotherapy Regimen.  The treatment regimen for all models began 24 hours after 
initial seeding and consisted of 72 hours of drug exposure—10 ng/mL for paclitaxel 
(Indena) and 1.5 µg/mL for cisplatin (Sigma-Aldrich)—followed by removal of drug and 
an additional 72 hours of culture. Paclitaxel Oregon Green ® 488 conjugate (Thermo 
Fisher Scientific) was used for treatment in the same manner as paclitaxel. 
Viability Measurements. After treatment of models with chemotherapeutics, cells were 
extracted as described in Section 3.2. The resulting suspension of cells was seeded in a 
monolayer for 12 hours. Cell viability was tested using a colorimetric MTS (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) 
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cell proliferation assay with absorbance read at 490 nm (Sigma-Aldrich).  Cell viability 
within each was calculated as a percentage of the untreated control of each model.  
Assessment of Drug Diffusion within 4 mg/mL Collagen Gels.  To ensure that the small 
molecule drugs cisplatin and paclitaxel were indeed reaching diffusion equilibrium within 
the 72 hr time frame of drug exposure, we developed a finite element model using 
COMSOL Multiphysics to estimate the diffusion kinetics of cisplatin and paclitaxel. We 
experimentally measured the diffusion coefficient of the small molecule Irgacure 2959 (I-
2959) (Sigma), which is similar in size to cisplatin and paclitaxel, within our collagen 
gels using a technique adapted from a previously published protocol
66
. Briefly, collagen 
gels were formed in the bottom of a 24-well glass bottom plate (Mattek). After collagen 
gel formation, a solution containing 0.4 wt% of I-2959 in 1x PBS was added and allowed 
to diffuse overnight. Upon starting the experiment, the media was removed and replaced 
with fresh 1x PBS. Samples of media were taken over the course of a two-hour period, 
and the concentration of I-2959 was determined by measuring absorbance at 290 nm with 
a SpectraMax M5 Plate Reader. The diffusion coefficient of I-2959 within our collagen 
gels was then calculated using the semi-infinite slab approximation
153
. We incorporated 
the experimentally measured collagen diffusion coefficient into our finite element model, 
and used it to study the diffusion kinetics of cisplatin and paclitaxel.  
Assessment of Drug Penetrance.  In order to confirm that drug was adequately 
penetrating the 3D embedded spheroid model, the embedded spheroid model was treated 
with Paclitaxel Oregon Green®, a fluorescent-analog of paclitaxel, and imaged at five 
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distinct z-positions within the spheroid: 0, 50, 100, 150, and 200 µm. The relative 
fluorescence of Paclitaxel Oregon Green® for the spheroid region, normalized to the 
surrounding background, was measured for each z-position.  
3.3.2 Results 
 Prior to assessing CSC content within each in vitro tumor model, we confirmed 
that the chemotherapy drugs readily diffused into our 3D collagen gels by developing a 
COMSOL Multiphysics finite element model to estimate the diffusion kinetics of small 
molecule drugs diffusing into our 3D collagen gels (Figure 3-4). Furthermore, we also 
confirmed that the drugs penetrate our spheroid model by assessing the presence of a 
fluorescent-analog of paclitaxel, Paclitaxel Oregon Green®, throughout the embedded 
spheroids (Figure 3-5). To estimate the diffusion coefficient of small molecules within 
our collagen gels, we experimentally measured the diffusion coefficient of the small 
molecule I-2959, which is similar in size to paclitaxel and cisplatin, within 4 mg/mL 
collagen gels. The diffusion experiments revealed I-2959 to have a diffusion coefficient 
equal to 3.3 ± 0.5 x 10
-10
 m
2
/s. Inputting this diffusion coefficient into our finite element 
model revealed that paclitaxel and cisplatin reach diffusive equilibrium within the first 16 
hours of drug treatment. Furthermore, the Paclitaxel Oregon Green® studies revealed that 
paclitaxel readily penetrates the spheroid as the fluorescent intensity did not significantly 
change as a function of distance into the spheroid (Figure 3-5). Therefore, these results 
confirm that the drug readily diffuses into 3D collagen gels and penetrates the 
multicellular spheroid.  
The high sensitivity of the TaqMan gene expression assay enabled us to quantify 
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the CSC content within our three in vitro models following treatment with either cisplatin 
or paclitaxel by assessing ALDH1A3, SOX2, OCT4, and NANOG expression. For the 
MDA.MB.231 conditions, treatment with paclitaxel led to a statistically significant 
increase in ALDH1A3 expression across all in vitro models compared to the 
corresponding untreated conditions (Figure 3-6a): fold-changes of 1.42 ± 0.15; 7.10 ± 
0.65; and 2.67 ± 0.40 (mean ± S.D., n = 3) were noted in the 2D monolayer, 3D diffuse, 
and 3D embedded spheroid core conditions, respectively. Also of note, paclitaxel 
treatment resulted in a small to non-existent periphery population due to lack of invasion. 
This inhibition of cellular invasion by paclitaxel has also been observed in a colon cancer 
transwell migration assay
154
, and is likely a result of paclitaxel’s mechanism of action, 
which is to stabilize cytoskeleton microtubules
155,156
. Therefore, no gene expression data 
was obtained for the paclitaxel-treated spheroid periphery population. Nonetheless, the 
results show that paclitaxel treatment enriches for cells expressing ALDH1A3. 
Additionally, there were increases in SOX2 expression following paclitaxel exposure in 
all in vitro models with fold-changes of 13.11 ± 0.81, 1.72 ± 0.93, and 2.39 ± 0.27 (mean 
± S.D., n = 3) in the 2D monolayer, 3D diffuse, and 3D spheroid core conditions, 
respectively (Figure 3-6b); again supporting the observation by us and others
5,141
 that 
paclitaxel treatment enriches for the CSC subpopulation. Interestingly, treatment with the 
DNA intercalating agent cisplatin significantly enriched for the expression of ALDH1A3, 
SOX2, OCT4, and NANOG within the 2D monolayer and 3D diffuse systems, but did not 
increase these genes within the core or periphery populations. (Figure 3-6a-d). Fold-
changes for each treatment condition with respect to the untreated control in each in vitro 
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model are shown in Table 3-3. 
 The CSC responses to cisplatin and paclitaxel were further investigated using the 
luminal breast cancer cell line MCF7. Here, the expression of ALDH1A3, SOX2, OCT4, 
and NANOG was quantified using the TaqMan gene expression assay across all three in 
vitro tumor models. For the untreated conditions, there were no statistical differences in 
CSC-related gene expression between in vitro tumor models except for SOX2, which 
showed a fold-change of 0.35 ± 0.02 in the spheroid model compared to the 2D 
monolayer (p<0.001) (Figure 3-8).  Notably, the MCF7 spheroids did not exhibit invasion 
into the surrounding collagen and therefore did not possess a periphery population 
(Figure 3-9). As a result, the gene expression of the entire spheroid was assessed and 
labeled as “3D spheroid”. 
 Following treatment with cisplatin, increases in ALDH1A3 were observed across 
all in vitro models: fold-changes of 3.67 ± 0.13, 6.32 ± 1.56, and 2.52 ± 0.35 for 2D 
monolayer, 3D diffuse, and 3D spheroid, respectively (mean ± S.D., n = 3) (Figure 3-8a).  
However, treatment with cisplatin led to a significant decrease in expression of SOX2 
within the 2D monolayer (0.54 ± 0.05; mean ± S.D., n = 3), and increased its expression 
in the 3D spheroid (1.48 ± 0.04; mean ± S.D., n = 3) (Figure 3-8b). Moreover, cisplatin 
treatment did not alter the expression of OCT4 or NANOG in any of the in vitro models 
(Figure 3-8c-d).  
 For paclitaxel, the expression of ALDH1A3 increased in the 2D monolayer (1.27 ± 
0.10; mean ± S.D., n = 3) and the 3D diffuse conditions (6.75 ± 1.14; mean ± S.D., n = 3), 
but remained unchanged in the 3D spheroid condition (Figure 3-6a). The expression of 
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SOX2 decreased in the 2D monolayer (0.74 ± 0.06; mean ± S.D., n = 3) and increased in 
the 3D spheroid (1.24 ± 0.11; mean ± S.D., n = 3) conditions (Figure 3-6b). However, 
paclitaxel treatment did not affect the expression of OCT4 or NANOG (Figure 3-6c-d). 
The fold-changes for each treatment condition with respect to the untreated control within 
each in vitro model are listed in Table 3-4. 
3.4 Investigating the Cisplatin Context-dependent Response 
The context-dependent response of the CSC subpopulation to cisplatin treatment 
within MDA.MB.231 in vitro tumor models illustrates the need for screening potential 
CSC-specific drugs using tumor models that recapitulate the tumor microenvironment 
better than conventional 2D monolayers or even 3D diffusely embedded cell culture 
systems. We therefore sought to explain this context-dependent cisplatin response, and 
hypothesized that a decreased proliferation rate in the non-CSC subpopulation within the 
embedded spheroid model may be responsible.  
To better illustrate how differences in proliferation rates may affect CSC 
enrichment following cisplatin treatment, Figure 3-10 depicts hypothetical drug-response 
curves for the CSC and non-CSC subpopulations within the 2D monolayer/3D diffuse 
(Figure 3-10a) and embedded spheroid models (Figure 3-10b). For the 2D monolayer and 
3D diffuse models, cells belonging to the non-CSC subpopulation are proposed to be 
more sensitive to cisplatin than CSCs, hence the leftward shift in their drug-response 
curve. This difference in sensitivity to cisplatin between non-CSCs and CSCs may be due 
to CSCs being less proliferative, expressing drug efflux transporters, and having higher 
levels of anti-apoptotic proteins
106
. However, if the non-CSC subpopulation were to 
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become less proliferative, as we hypothesized to be the case in the embedded spheroid 
model, this could cause a rightward shift in the drug-response curve as cisplatin is most 
effective against actively proliferating cells. Therefore, we hypothesized that the 
observed lack of CSC enrichment within the spheroid model following cisplatin 
treatment was due to a decreased overall proliferation rate compared to the 2D monolayer 
or 3D diffuse conditions. We therefore investigated this hypothesis by performing 
immunofluorescent staining for the proliferation marker Ki67 for all three MDA.MB.231 
in vitro models.  
3.4.1 Materials and Methods 
Immunofluorescent Imaging. To quantify the proliferation rate within each in vitro model, 
we measured the presence of the proliferation marker Ki67 via immunofluorescence. For 
the 2D monolayer condition, cells were fixed with 4% paraformaldehyde (PFA) for 15 
min at room temperature and blocked with 1% BSA and 0.1% Triton X-100 for 1 hr at 
room temperature. Following blocking, samples were incubated with Ki67 primary 
antibody (PA5-16785, ThermoScientific (1:100 dilution)) overnight at 4
o
C. After 
incubation of the primary antibody, samples were incubated with an AlexaFluor 488-
conjugated secondary antibody (Invitrogen (1:500 dilution)) for 1 hr at room temperature. 
Nuclear staining was performed using the cyanine nucleic acid dye BOBO-3 Iodide 
(ThermoFisher) at a concentration of 10 µM and incubated at room temperature for 30 
min. To improve the specificity of the nuclear stain, 0.2 mg/mL of RNase A 
(ThermoFisher) was added to the BOBO-3 staining solution. For the 3D diffuse condition, 
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incubation times were increased two-fold to ensure sufficient diffusion of the reagents 
throughout the collagen gels.  
 To assess the proliferation rate within the embedded spheroid model, we 
performed cryosectioning prior to immunostaining. Here, embedded spheroids were fixed 
with 4% PFA for 30 min at room temperature, embedded within OCT compound, and 
immediately immersed within liquid nitrogen. Cryosectioning was performed using a 
HM525 NX Cryostat (ThermoFisher) and 300 µm-thick sections were taken. After 
cryosectioning, samples were thawed onto #0 coverslips. Immunofluorescent staining 
was performed in the same manner as the 3D diffuse conditions.  
3.4.2  Results 
By performing immunofluorescent staining for the proliferation marker Ki67 
within the three in vitro tumor models, we found that the 2D monolayer had the greatest 
proliferation rate with over 75% of the population staining positive for Ki67 (Figure 3-
11). The 3D diffuse model had a slight, but statistically significant decrease in 
proliferation rate with approximately 60% of the population staining positive for Ki67 
(Figure 3-11). However, the embedded spheroid model had the lowest proliferation rate 
with ~5% and ~10% staining positive for Ki67 in the spheroid core and spheroid 
periphery populations, respectively (Figure 3-11).   
The Ki67 immunostaining results support our hypothesis as the two in vitro 
models with the greatest proliferation, the 2D monolayer and 3D diffuse, also exhibit an 
enriched CSC subpopulation following cisplatin treatment. For the spheroid conditions, 
we hypothesize that the lower overall proliferation rate, which is likely due to cell contact 
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inhibition from the in vivo-like multicellular architecture, no longer confers selective 
advantage to the CSC subpopulation.  
3.5 Discussion 
 The aim of this work was to investigate the clinical relevance of three in vitro 
tumor models by quantifying CSC content before and after chemotherapeutic intervention 
with two front-line therapies: cisplatin and paclitaxel. The 3D embedded spheroid model 
recreates a phenotypic landscape, possessing an enriched and spatially-dependent CSC 
population, that reflects the phenotypic cellular heterogeneity found in vivo. Importantly, 
the results indicate that both the 2D monolayer and 3D diffuse models are inadequate for 
assessing stemness and drug efficacy, findings that are supported by the clinical 
observations of chemoresistance despite in vitro susceptibility. While simply embedding 
single cells within 3D collagen matrices overcomes the limitation of forced cell 
polarization associated with 2D culture, it fails to impart important cell-cell interactions 
known to be intricately involved in promoting tumor progression
157–159
. Consequently, 
the 3D diffuse model yielded results similar to the 2D monolayer. 
 Quantifying the CSC content within the three in vitro tumor models using 
MDA.MB.231 cells revealed that the embedded spheroid model had an enriched CSC 
subpopulation. Three independent assays corroborated this observation as the 
ALDEFLUOR, mammosphere, and RT-qPCR gene expression assays all showed an 
enriched CSC subpopulation in the spheroid model (Figure 3-3). Moreover, CSC content 
within the spheroid model also appeared to be spatially-dependent as the core population 
had a larger ALDH
+
 population, greater potential to form mammospheres, and higher 
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expression of ALDH1A3 and OCT4 than the periphery population (Figure 3-3). 
Additionally, expression of stem cell-related genes: SOX2, OCT4, and NANOG were 
upregulated in all spheroid conditions. Importantly, SOX2 is a key transcription factor 
involved in embryonic stem cell self-renewal and is correlated with poor patient 
prognosis in breast cancer
108,160,161
. 
 Interestingly, when we investigated the expression of CSC-related genes in the 
luminal breast cancer cell line MCF7 without drug treatment, the expression of 
ALDH1A3, SOX2, OCT4, and NANOG were not significantly different across in vitro 
tumor models. This result contradicts the MDA.MB.231 results and suggests that the 
CSC content within the MCF7 cell line is less sensitive to changes in tumor architecture, 
at least within our models. The results with the MCF7 cells are also in contrast to a report 
describing the expression of SOX2 and OCT4 increasing 2-fold when cultured within 3D 
collagen gels
162
. However, the collagen gel used in that study had a macroporous 
structure and was covalently crosslinked with 1-ethyl-3-(3-dimethyl aminopropyl) 
carbodiimide (EDC). Thus, the collagen gels used in these two studies possess different 
physical and mechanical properties, and suggests that collagen composition itself may 
alter CSC content, an interesting result that may warrant further study. 
Treatment with paclitaxel significantly enriched for ALDH1A3 in all 
MDA.MB.231 in vitro models as well as in the MCF7 2D monolayer and 3D diffuse 
models. The enriched CSC population following paclitaxel treatment may be due to 
effective intervention against the non-stem-like population. In addition to the role of 
ALDH as a promoter of stemness through altered retinoid signaling
163
, ALDH also acts 
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as a scavenger of reactive oxygen species (ROS)
164,165
. This ROS scavenging role 
provides a mechanism by which CSCs can evade therapeutic intervention through 
suppression of ROS-induced apoptotic mechanisms. Notably, there is experimental 
evidence indicating that at least part of paclitaxel and cisplatin’s efficacy is due to the 
generation of ROS
166,167
. Interestingly, the MCF7 spheroid model did not show 
enrichment of ALDH1A3 following paclitaxel treatment, indicating that the CSC and non-
CSC MCF7 subpopulations exhibit equivalent resistance to paclitaxel within the spheroid 
model. This observation may reflect clinical evidence showing that the bulk populations 
of luminal breast cancers are more resistant to paclitaxel than other breast cancer 
subtypes
168,169
. 
Cisplatin treatment led to a significant increase in ALDH1A3 expression in the 
MDA.MB.231 2D monolayer and 3D diffuse conditions, but did not affect its expression 
within the core population, and actually reduced its expression in the spheroid periphery 
population. These results indicate that the chemotherapeutic response of MDA.MB.231s 
to cisplatin is context-dependent and is affected by the multicellular architecture. To 
explain this context-dependent result, we hypothesized that the relative proliferation rates 
between CSCs and non-CSCs influence the outcome. In 2D culture, CSCs proliferate 
more slowly compared to their non-CSC counterparts
126,170–174
, and given that cisplatin 
affects faster proliferating cells more effectively than slower proliferating cells
175
, we 
suggest that for conditions in which there are differences in relative proliferation rates 
between CSC and non-CSCs, cisplatin treatment will enrich for the slower proliferating 
CSC subpopulation. Therefore, we measured the presence of the proliferation marker 
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Ki67 within each of our in vitro models, and found that CSC enrichment from cisplatin 
correlated with faster proliferation rates. 
As for the minimal change in expression of SOX2, OCT4, and NANOG following 
therapeutic treatment in the MCF7 cells, this may be due to MCF7 being a luminal breast 
cancer subtype as expression of these genes have been correlated with the triple-negative 
basal breast cancer subtype (e.g. MDA.MB.231s) rather than the luminal subtype
48
. 
However, ALDH1A3 expression is still a valid marker for CSC content within the MCF7 
cell line as ALDH
+
 MCF7 cells are more tumorigenic than their ALDH- counterparts
176
. 
In summary, the embedded spheroid model recapitulates cell-cell and cell-matrix 
interactions found within the native tumor microenvironment. Furthermore, it enables us 
to better characterize the CSC response to chemotherapy. To this end, we found that 
treatment with paclitaxel or cisplatin alone do not effectively combat tumor growth—
consistent with many clinical outcomes—and the results are model dependent (2D vs. 
3D). Therefore, given the complexity of in vivo tumors, opportunities exist to develop 
tumor models that enable studies from mechanistic cell-cell or cell-matrix signaling to 
drug screening
177,178
. To this end, the 3D embedded spheroid model recreates these 
interactions and reflects the cellular and metabolic heterogeneity found within tumors 
including the role of cancer stem cells, which are linked to chemoresistance, recurrence, 
metastasis, and progression
106,126
.  
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Figure 3-1: Overview of In Vitro Tumor Models 
The in vitro tumor models investigated in this study were a) 2D monolayer, b) 3D 
diffusely embedded, and c) 3D embedded multicellular spheroid. For the 3D models, 
cells were embedded within 4 mg/mL 3D collagen type-I gels. Moreover, the 3D 
embedded spheroid model displayed two distinct cell populations, a compact core and a 
periphery composed of cells that had invaded into the surrounding matrix.  
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Figure 3-2: Isolation of Core and Periphery Populations from 3D Collagen-
embedded Multicellular Spheroids 
The core and periphery populations from 3D collagen-embedded multicellular spheroids 
were isolated by the following protocol: 1) degradation of collagen with collagenase 
type-I, 2) isolation of compact core population via pipette, and 3) disaggregation of 
compact core by trypsin/EDTA treatment.  
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Figure 3-3: CSC Markers Are Enriched within the 3D Embedded Core Population 
of MDA.MB.231 Spheroids  
CSC markers are enriched within the 3D embedded core population of MDA-MB-231 
spheroids. a) ALDEFLUOR assay results from the three untreated in vitro tumor models. 
Error bars represent mean ± SD; n = 3. P value was determined using ANOVA with 
Tukey-Kramer post hoc analysis (*P < 0.05, **P < 0.01). b) ALDEFLUOR assay results 
for untreated 3D spheroid core and periphery populations (normalized to core 
population). Error bars represent mean ± SD; n = 3. P value was determined using 
Student’s t-test (*P < 0.05). c) Mammosphere assay results from the untreated in vitro 
models. Error bars represent mean ± SD; n = 3. P value was determined using ANOVA 
with Tukey-Kramer post hoc analysis (**P < 0.01, ***P < 0.001). d) RT-qPCR 
analysis of ALDH1A3, SOX2, OCT4, and NANOG gene expression in the untreated in 
vitro models. Gene expression is normalized to ACTB expression as an internal control. 
Error bars represent mean ± SD; n = 3. P value was determined using ANOVA with 
Tukey-Kramer post hoc analysis (**P < 0.01, ***P < 0.001).  
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Table 3-1: List of TaqMan Gene Expression Assay Probes 
The genes and corresponding assay IDs are shown. All probes were purchased from 
ThermoFisher Scientific.  
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Table 3-2: Gene Expression Across MDA.MB.231 In Vitro Tumor Models 
Normalized to the 2D Monolayer 
The fold-change in gene expression is shown across in vitro models (normalized to 2D 
monolayer) for ALDH1A3, SOX2, OCT4, and NANOG. Data shown as mean ± S.D., n = 3.  
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Figure 3-4: COMSOL Multiphysics Finite Element Model Reveals Drugs Readily 
Diffuse into 3D Collagen Gels 
a) The finite element model of small molecule chemotherapy drugs diffusing into our 3D 
collagen gels is shown. Our experimental results revealed I-2959, which is similar in size 
to cisplatin and paclitaxel, to have a diffusion coefficient within our collagen gels equal 
to 3.3 ± 0.5 x 10
-10
 m
2
/s. b) Incorporating these results into our finite element model 
enabled us to predict that the chemotherapy concentration within our 3D collagen gels 
reaches diffusive equilibrium within 16 hours.  
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Figure 3-5: The Paclitaxel-analog Shows Paclitaxel Diffuses into the MDA.MB.231 
Embedded Spheroid Model 
The embedded spheroid model was treated with Paclitaxel Oregon Green®, a fluorescent 
analog of paclitaxel and imaged at five distinct z-positions: a) 0 µm, b) 50 µm, c) 100 
µm, d) 150 µm, and e) 200 µm. The embedded spheroid model imaged with DIC at 0 µm 
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is shown in f). The relative fluorescence of Paclitaxel Oregon Green® for the spheroid 
region, normalized to the surrounding background, was measured for each z-position g). 
The fluorescent intensity did significantly change as a function of distance into the 
spheroid (mean ± S.D., n = 3). 
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Figure 3-6: CSC-related Gene Expression in MDA.MB.231s in Response to 
Treatment with Either Cisplatin or Paclitaxel 
The gene expression of a) ALDH1A3, b) SOX2, c) OCT4, and d) NANOG following 
treatment with either cisplatin (orange) or paclitaxel (red) compared to untreated 
conditions (blue) are shown. Gene expression was normalized to the internal control gene 
ACTB. All genes were analyzed in triplicate and the results are shown as mean ± S.D. P 
values were determined using ANOVA with Tukey-Kramer post hoc analysis (*P < 0.05, 
**P < 0.01, ***P < 0.001). Note: paclitaxel treatment in the embedded spheroid model 
effectively eradicated the periphery population.  
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Table 3-3: Gene Expression Across MDA.MB.231 In Vitro Tumor Models Following 
Treatment with Paclitaxel or Cisplatin 
The fold-change in gene expression is shown following chemotherapeutic intervention 
across in vitro models (normalized to untreated condition within each in vitro model) for 
ALDH1A3, SOX2, OCT4, and NANOG. Data shown as mean ± S.D., n = 3.  
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Figure 3-7: CSC-related Gene Expression in the Luminal Breast Cancer Cell Line 
MCF7 Across In Vitro Tumor Models 
The gene expression of ALDH1A3, SOX2, OCT4, and NANOG were investigated in the 
untreated in vitro models for MCF7. Gene expression was normalized to the internal 
control gene ACTB. All genes were analyzed in triplicate and the results are shown as 
mean ± S.D. P values were determined using ANOVA with Tukey-Kramer post hoc 
analysis (*P < 0.05, **P<0.01, ***P<0.001).  
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Figure 3-8: CSC-related Gene Expression in the Luminal Breast Cancer Cell Line 
MCF7 Following Treatment with Cisplatin or Paclitaxel Across In Vitro Tumor 
Models 
The MCF7 gene expression of a) ALDH1A3, b) SOX2, c) OCT4, and d) NANOG 
following treatment with either cisplatin (orange) or paclitaxel (red) compared to 
untreated controls (blue) are shown. Gene expression was normalized to the internal 
control gene ACTB. All genes were analyzed in triplicate and the results are shown as 
mean ± S.D. P values were determined using ANOVA with Tukey-Kramer post hoc 
analysis (*P < 0.05, **P<0.01, ***P<0.001).   
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The untreated MCF7 3D spheroid model embedded within 4 mg/mL collagen gels on 
Day 7 is shown. 
  
Figure 3- 9: MCF7 Spheroid Morphology on Day 7 
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Table 3-4: Gene Expression Across MCF7 In Vitro Tumor Models Following 
Treatment with Paclitaxel or Cisplatin. 
 
The fold-change in gene expression is shown for the luminal breast cancer cell line 
MCF7 following chemotherapeutic treatment (normalized to the untreated condition 
within each in vitro model). Data presented as mean ± S.D., n = 3.  
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Figure 3-10: Proposed Drug Response Curves for CSC and Non-CSC (Bulk) 
Populations in 2D Monolayer/3D Diffuse and 3D Spheroid In Vitro Tumor Models 
We propose that the enriched CSC subpopulation observed following treatment with 
cisplatin in the 2D monolayer and 3D diffuse models is due to the CSC subpopulation 
being inherently more resistant to chemotherapeutic intervention than the non-CSC 
subpopulation (i.e. Bulk Tumor Population) as CSCs have slower cell cycling and higher 
expression of drug efflux transporters and anti-apoptotic genes
106
. However, the 
enrichment of CSCs may become negligible or even reversed if the non-CSC 
subpopulation becomes more resistant to chemotherapy. Therefore, for the 3D spheroid 
model, we propose that the observed lack of CSC enrichment following treatment with 
cisplatin is due to a slower proliferation rate in the non-CSC subpopulation. The slower 
proliferation rate causes the non-CSC subpopulation to become more resistant to cisplatin, 
and causes the non-CSC dose response curve to shift towards the dose response curve for 
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the CSC subpopulation.  In such a scenario, drug treatment would not enrich for the CSC 
subpopulation. 
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Figure 3-11: Quantification of Proliferation via Immunofluorescent Imaging of Ki67 
within MDA.MB.231 In Vitro Tumor Models 
The presence of the proliferation marker Ki67 was measured across our in vitro tumor 
models and representative images are shown: a) 2D monolayer, b) 3D diffuse, and c) 
embedded spheroid. The boundary between the “Spheroid Core” and “Spheroid 
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Periphery” populations was identified by visual inspection of cell morphology as cells 
remaining in the core exhibited elongated morphologies tangential to the spheroid surface. 
Nuclei are shown in blue (BOBO-3) and Ki67 is shown in green. The percentage of 
Ki67
+
 cells was calculated using ImageJ’s automated cell counting plug-in d). The 2D 
monolayer had the greatest percentage of Ki67
+
 cells, and was statistically significant 
from all other conditions. The spheroid periphery population had a modest increase in 
proliferation compared to the core, but it was still significantly lower than both the 2D 
monolayer and 3D diffuse conditions. The results are shown as mean ± S.D.; n = 15 for 
the 2D monolayer and 3D diffuse conditions, n = 3 for the spheroid conditions. P value 
was determined using ANOVA with Tukey-Kramer post hoc analysis (*P<0.05, 
***P<0.001).  
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CHAPTER 4. Development and Experimental Validation of a Mathematical Model 
of YAP/TAZ Signaling 
4.1 Introduction 
In healthy tissues, the YAP/TAZ signaling pathway has been shown to regulate 
cellular growth and maintain homeostasis
179
. Traditionally, this pathway has been studied 
by investigating the role of cell-cell adhesion and cell polarity molecules, including E-
cadherin
180
, NF2(merlin)
179
, and Crumbs
181
. These molecules ultimately act on the core 
kinases LATS1/2, which phosphorylate YAP and TAZ and thereby prevent them from 
localizing to the nucleus. However, if YAP and TAZ become activated and translocate to 
the nucleus, they induce proliferation, resistance to apoptosis, and maintenance of 
stemness
179
.  
Importantly, YAP/TAZ signaling has been shown to be overactive in late-stage 
cancers
182,183
, yet mutations within their upstream signaling cascade are rare
182
. This 
therefore suggests that YAP/TAZ overactivation in cancer may be a result of external 
microenvironmental cues such as an aberrant multicellular architecture and a stiffened 
ECM. Furthermore, despite the importance of YAP/TAZ in cancer, how its 
overactivation arises is unclear. Therefore, we developed and experimentally validated a 
mathematical model of YAP/TAZ signaling.  
4.2 Mathematical Model 
 The mathematical model developed in this work integrates two cellular signaling 
pathways: 1) ECM mechanosensing and 2) cell-cell contact sensing (Figure 4-1). The 
ECM mechanosensing component is an expansion of our previous work
184
, and the cell-
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cell contact sensing component incorporates the Hippo signaling pathway, which has 
previously been shown to regulate YAP/TAZ activity
185
. Broadly, the model quantifies 
the concentration of molecules within various cellular compartments for individual cells 
using ordinary differential equations (e.g. YAP/TAZ localization in the cytoplasm vs. 
nucleus or F-actin in the cellular cortex vs. non-cortex).  
 With regards to cell-cell contact sensing, cells interact with each other through 
cell-cell contact structures such as adherens junctions (AJ) and tight junctions. Within 
AJs, cadherin proteins (e.g. E-cadherin) are anchored to the cellular membrane and 
contain a cytoplasmic domain that interacts with p120 catenin, α-catenin, and β-catenin, 
which subsequently link AJs with the actin cytoskeleton
186,187
. In our mathematical model, 
we used E-cadherin recruitment as a proxy to represent cell-cell adhesion complex 
formation and described using the following equations: 
 
where EcadAJ(t) is the concentration of E-cadherin recruited to AJs, Factincortical(t) is the 
F-actin concentration in the cortical domain, Factinnoncortical(t) is the F-actin concentration 
in the non-cortical domain, and Actin0 is the total concentration of actin molecules, which 
is assumed to be constant independent of substrate stiffness or cell density
188
. Moreover, 
for simplicity, E-cadherin concentration within AJs represent both AJ and tight junction 
activity, forming key upstream components of the Hippo pathway
180
. f1(CellDensity(t)) 
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and f2(CellDensity(t)) are functions of cell density, measured by the number of cells per 
image and are defined as: 
 
 In addition to AJs, apical-basal polarity is also an important upstream regulator of 
Hippo signaling. Here, the polarity molecules Crumbs3
181
 and Scribble
7,189,190
 have been 
shown to regulate the phosphorylation of Large Tumor Suppressor Kinases 1 and 2 
(LATS1/2), which in turn phosphorylate YAP and TAZ and promote their retention in the 
cytoplasm
185
. To incorporate apical-basal polarity into our mathematical model, we 
constructed a system of equations in which AJ activity, represented by the accumulation 
of E-cadherin at AJs, promotes apical-basal polarity via a positive feedback loop of the 
Crumbs3 and Scribble complexes
191–193
. The apical-basal polarity equations are the 
following:  
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(11) 
(12) 
where CrbAD(t) and CrbBLD(t) are the Crumbs3 concentrations in the apical and 
basolateral domain, respectively. ScbAD(t) and ScbBLD(t) are the Scribble concentrations in 
the apical and basolateral domains, respectively.  
The relationship between Crumbs3 and LATS kinases was described using the 
following equations: 
 
where LATS0 is the total number of LATS proteins and LATSP(t) is the number of 
phosphorylated LATS proteins. YAP/TAZ0 is the total number of YAP/TAZ molecules 
and YAP/TAZN is the number of YAP/TAZ molecules in the nucleus.  
 In addition to the cell-cell contact-sensing signaling pathway, we expanded our 
previously published ECM mechanosensing model
184
 by incorporating the remodeling of 
myosin and F-actin in the non-cortical domain: 
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where myosin0 is the total number of myosin molecules, myosinA(t) is the number of 
activated myosin molecules, ROCKA(t) is the number of activated ROCK molecules, and 
mDiaA(t) is the number of activated mDia molecules. 
 Finally, as YAP/TAZ signaling has previously been shown to promote cellular 
proliferation, we linked YAP/TAZ activity with Ki67 concentration, a marker of 
proliferation, via the following equation:  
 
where Ki67(t) is the number of Ki67 molecules as a function of time. 
4.3 Measuring YAP/TAZ Nuclear Fraction as a Function of Cell Density and 
Substrate Stiffness 
 In order to experimentally validate our mathematical model of YAP/TAZ 
signaling, we measured the YAP/TAZ nuclear fraction of two cell lines, the non-
cancerous cell line MCF10A and the triple negative breast cancer cell line MDA.MB.231, 
as a function of cell density and substrate stiffness. To this end, cells were cultured on 
either 2D collagen-coated polyacrylamide or 2D collagen-coated glass, and the 
YAP/TAZ nuclear fraction was measured using immunofluorescent imaging.  
4.3.1  Materials and Methods 
Cell Culture.  The triple negative breast cancer cell line MDA.MB.231 was cultured in 
DMEM with 10% FBS and 1% penicillin/streptomycin. The non-cancerous cell line 
MCF10A was cultured in Growth Media according to a previously published protocol
194
. 
(13) 
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For the sparse, confluent, and dense conditions; cells were seeded at densities of 6.2 x 10
3
, 
6.2 x 10
4
, and 2.6 x 10
5
 cells per cm
2
, respectively. 
Preparation of Polyacrylamide Substrates.  Two-dimensional polyacrylamide substrates 
were prepared using a method adapted from a previously published protocol
195
. Briefly, 
substrates were formed by sandwiching 5 µL of polyacrylamide solution between an 8 
mm round-coverslip and an 8-well chambered glass coverslip with #1.5 coverglass 
(Cellvis). Prior to the addition of polyacrylamide, the 8-well chambered glass coverslip 
was functionalized with 1.1 mM of 3-(trimethoxysilyl) propyl methacrylate (BIND 
Silane) in 7 mM Acetic Acid, Glacial (Sigma-Aldrich). Following gel formation, 
substrates were sterilized via three washes with 70% ethanol and 30 min of UV light, 
and allowed to equilibrate in sterile PBS overnight. 
Mechanical Characterization of Polyacrylamide Substrates.  The mechanical properties 
of the polyacrylamide substrates were evaluated using a PIUMA Nanoindenter (Optics 
11, Amsterdam, Netherlands). To this end, polyacrylamide gels were indented at a 
constant strain rate (10 µm/s) by a 20.5 m diameter probe with a cantilever stiffness of 
0.066 N/m. The resulting force-displacement curves were converted into indentation 
stress-strain using the Hertzian contact model, assuming a linear elastic and isotropic 
material response, and the elastic modulus was taken as the slope of stress-strain curve 
within the linear region. For each sample, a total of five indentations were made into the 
sample at five different locations separated by more than 500 µm. 
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Preparation of Collagen-coated Polyacrylamide Substrates.  For cell adhesion, collagen 
I protein (Corning) was covalently bonded to the surface of the polyacrylamide 
substrates using the heterobifunctional linker Sulfo-SANPAH (Pierce). Here, 0.5 mM of 
sulfo-SANPAH solution in 50 mM HEPES at pH 8.5 was pipetted onto the substrates 
and irradiated for 10 min with 365 nm UV light from an 8-watt UV Lamp (Pierce). The 
substrates were washed once with HEPES solution, and the sulfo-SANPAH treatment 
was repeated one time. Following the second sulfo-SANPAH treatment, the surfaces 
were washed three times with HEPES solution to remove excess sulfo-SANPAH. A 
uniform collagen coating was achieved by pipetting 0.1 mg/mL of collagen solution in 
PBS at pH 7.3 onto the substrates and incubating at 4°C overnight. The uniformity was 
confirmed by immunofluorescent imaging with an anti-collagen type-I antibody (Abcam 
ab34710). 
Preparation of Collagen-coated Glass Substrates.  Collagen-coated glass substrates were 
formed by adding 0.1 mg/mL solution of collagen type-I in PBS at pH 7.3 directly to 8-
well chambered glass slides, and incubating at 4°C overnight. 
Immunofluorescence Staining and Microscopy.  After 48 hours of culture on substrates, 
cells were fixed with 4% PFA for 15 minutes and permeabilized with 0.1% Triton X-100 
for 15 minutes at room temperature. Samples were then blocked with 1% bovine serum 
albumin (BSA) and 0.1% Triton X-100 for 1 hour at room temperature. Following 
blocking, samples were incubated with primary antibodies for 2 hours at room 
temperature, and with Alexa Fluor 488-conjugated secondary antibody (Invitrogen) for 1 
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hour at room temperature (1:500). Antibody information is shown in (Table 4-1). Nuclear 
staining was performed using the cyanine nucleic acid dye BOBO-3 Iodide 
(ThermoFisher) at a concentration of 1 µM for the sparse conditions and 10 µM for the 
confluent and dense conditions, and incubated at room temperature for 30 min. To 
improve the specificity of the nuclear stain, 0.2 mg/mL of RNase A (ThermoFisher) was 
added to the BOBO-3 staining solution. 
Image Analysis.  The image acquisition was performed as previously described in Section 
3.4. Here, image stacks of MCF10A and MDA.MB.231 cells were taken, and the z-slice 
with the highest averaged pixel intensity in the BOBO-3 nuclear channel was selected for 
analysis. A custom-written image analysis algorithm was developed in MATLAB 
(R2009b, MathWorks Inc., USA) to extract nuclei areas in a semi-automatic approach. 
First, the image contrast within the BOBO-3 channel was enhanced using histogram 
equalization to distinguish individual nuclei. Then, using the center of each nuclei, 
Voronoi tessalation was applied to estimate each cell’s cytoplasmic area and border196,197. 
The YAP/TAZ signal was normalized to background signal, and the ratio of averaged 
YAP/TAZ intensity in the nuclei region to that in the cytoplasm was calculated. Based on 
visual comparison, cells with YAP/TAZ ratios greater than 1.11 have YAP/TAZ mainly 
in the nuclei, whereas cells possessing ratios less than 0.96 were found to have mostly 
cytosolic YAP/TAZ, and cells with ratios between 0.96 and 1.11 had YAP/TAZ present 
in both the cytoplasm and nucleus. After the YAP/TAZ nuclear ratio per cell was 
calculated, ratio thresholds were applied to categorize cells into ‘mainly nuclear’, ‘mainly 
cytosolic’, or ‘nuclear and cytosolic’. The average YAP/TAZ nuclear fraction was 
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calculated by summing the number of ‘mainly nuclear’ and one half of the ‘nuclear and 
cytosolic’ cells within an image, and dividing it by the total number of cells in an image: 
𝑌𝐴𝑃/𝑇𝐴𝑍𝑛𝑢𝑐𝑙𝑒𝑎𝑟 =
 𝑁𝑐𝑒𝑙𝑙𝑠 𝑤𝑖𝑡ℎ 𝑚𝑎𝑖𝑛𝑙𝑦 𝑛𝑢𝑐𝑙𝑒𝑎𝑟 +
1
2 (𝑁𝑐𝑒𝑙𝑙𝑠 𝑤𝑖𝑡ℎ 𝑛𝑢𝑐𝑙𝑒𝑎𝑟 𝑎𝑛𝑑 𝑐𝑦𝑡𝑜𝑠𝑜𝑙𝑖𝑐)
𝑁𝑡𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙𝑠
 
4.3.2 Results 
 As a first check of our mathematical model, we demonstrated that the model 
captured the inverse relationship between YAP/TAZ activity (quantified by YAP/TAZ 
nuclear fraction) and cellular density (Figure 4-2), as previously reported
82
. To this end, 
we investigated the YAP/TAZ nuclear localization within the non-cancerous epithelial 
cell line MCF10A when cultured at varying cell densities and on differing substrate 
stiffnesses. Here, the model reflected experimental results, and revealed that the 
YAP/TAZ nuclear fraction increases with increasing substrate stiffness and decreases 
with increasing cell density (Figure 4-2). Moreover, cell density and substrate stiffness 
jointly regulate YAP/TAZ nuclear localization as increasing substrate stiffness shifts the 
nuclear YAP/TAZ localization curve toward higher cell densities (Figure 4-2). Also, it 
should be noted that cells were seeded at three initial densities 6.2 x 10
3
, 6.2 x 10
4
, and 
2.6 x 10
5
 cells per cm
2
, which we termed ‘sparse’, ‘confluent’, and ‘dense’, respectively. 
The ‘sparse’ condition yielded fewer than 5 cells per image, the ‘confluent’ condition 
yield approximately 20 cells per image, and the ‘dense’ condition yielded more than 40 
cells per image.  
For the ‘sparse’ condition, in which cell-cell interactions are minimal and thus 
LATS1/2-mediated Hippo signaling is presumed to be negligible, our mathematical 
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model predicted the YAP/TAZ nuclear fraction to rise monotonically with increasing 
substrates stiffness: ~40%, ~60%, and ~90% for 1 kPa, 24 kPa, and glass, respectively 
(Figure 4-3a). However, upon reaching ‘confluency’ (i.e. the cell density at which cells 
form a uniform monolayer), YAP/TAZ localization was exclusively cytosolic, regardless 
of substrate stiffness, indicating that the cell-cell contact sensing pathway dominates the 
cell-ECM mechanosensing pathway (Figure 4-3a). This result was also observed within 
the ‘dense’ condition as YAP/TAZ localization was mostly cytosolic even at high 
substrate stiffnesses (Figure 4-3b). While these results are mediated, in part, through 
LATS1/2-regulated Hippo signaling, literature has shown that LATS1/2 alone cannot 
completely explain these results as YAP/TAZ phosphorylation levels plateau at confluent 
cell densities, while nuclear YAP/TAZ localization continues to decrease with increasing 
cell density
82
. Therefore, these results suggest that an additional mechanism, independent 
of LATS1/2-mediated Hippo signaling, may affect YAP/TAZ nuclear localization at high 
cell densities. This additional mechanism has previously been suggested to be regulated 
through actomyosin activity
82
, but how the actomyosin cytoskeleton is remodeled as a 
function of cell density and substrate stiffness is not clear. Therefore, we set out to unveil 
the mechanisms underlying this regulation.  
 We hypothesized that within the ‘dense’ condition, YAP/TAZ nuclear 
localization is attenuated by a concurrent shift in actin localization from non-cortical 
actin stress fibers to cortical F-actin. The rationale for proposing this shift in actin 
localization is that higher cell densities physically constrain cells and inhibit Rho/ROCK 
signaling, which in turn cause the actomyosin cytoskeleton to shift from non-cortical 
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stress fibers to cortical F-actin
83,89
. To test this hypothesis, we first calculated the shift in 
cortical and non-cortical F-actin structures using our mathematical model as a function 
of cell density and substrate stiffness. Our model predicted that actin would be 
predominantly located in the cellular cortex at high cell densities (Figure 4-4a). We 
experimentally validated our model’s predictions by imaging F-actin via 
immunofluorescence for MCF10A cells seeded on glass at varying cellular densities. 
Here, sparsely seeded cells had pronounced stress fibers while cells within the dense 
condition exhibited mostly cortical F-actin (Figure 4-4b). Notably, the number of stress 
fibers were not significantly different between the ‘sparse’ and ‘confluent’ cell densities, 
despite significant differences in YAP/TAZ nuclear fraction, which indicates that 
LATS1/2-mediated Hippo signaling is likely primarily responsible for attenuating 
YAP/TAZ nuclear localization in the confluent condition. Taken together, the MCF10A 
results demonstrate that YAP/TAZ activity is regulated through an AND gate; YAP/TAZ 
nuclear localization requires both the cellular density to be sparse enough to overcome 
LATS1/2-mediated Hippo signaling and the underlying substrate stiffness to be stiff 
enough to promote cytoskeletal tension via non-cortical F-actin fibers.  
 While normal YAP/TAZ signaling has been shown to be critical in regulating 
morphogenesis and healthy tissue function
179
, overactive YAP/TAZ signaling is 
associated with high grade cancers
7,23,182,198
. Interestingly, mutations rarely occur within 
the YAP/TAZ signaling pathway, indicating that external cues from the tumor 
microenvironment lead to YAP/TAZ dysregulation
7
. Therefore, to understand how 
microenvironmental cues affect YAP/TAZ signaling within cancerous cells, we applied 
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our mathematical model to the triple negative breast cancer cell line MDA.MB.231.  The 
MDA.MB.231 cell line provides an excellent system in which to investigate the substrate 
mechanosensing portion of YAP/TAZ signaling as MDA.MB.231 cells do not display 
apical-basal polarity or significant E-cadherin expression
180
.  
For the MDA.MB.231 cells, the YAP/TAZ nuclear fraction was consistently 
higher than in the MCF10A cells for a given cell density and substrate stiffness, 
indicating that the basal activity of YAP/TAZ is higher within MDA.MB.231 cells than 
MCF10A cells (Figure 4-5). However, even with negligible Hippo signaling, the 
MDA.MB.231 cells still exhibited density-dependent YAP/TAZ nuclear attenuation 
(Figure 4-5).  
 To better understand the observed cell density-mediated attenuation of YAP/TAZ 
nuclear localization from our MDA.MB.231 experiments, we used our computational 
model to investigate potential mechanisms. Based on model results, we found that a 
synergistic relationship exists between a loss of E-cadherin and an increase in non-
cortical F-actin, which together promote YAP/TAZ nuclear localization (Figure 4-6). 
This increased non-cortical F-actin present within MDA.MB.231 cells, as compared to 
MCF10A cells, agrees with previous reports showing that MDA.MB.231 cells generate 
greater traction forces
199
.    
4.4 Investigating YAP/TAZ Downstream Proliferation Activity 
 In order to confirm that YAP/TAZ nuclear localization was a valid estimate of 
YAP/TAZ activity, we assessed cellular proliferation as a function of cell density and 
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substrate stiffness as YAP/TAZ signaling had previously been shown to regulate cellular 
proliferation
123
.  
4.4.1 Materials and Methods 
 Polyacrylamide substrates were prepared and seeded with cells as previously 
described in Section 4.3. Proliferation was assessed by fixing cells with 4% PFA and 
performing immunofluorescent staining of the proliferation marker Ki67. The 
immunofluorescent staining protocol and image analysis were similar to the methods 
described for YAP/TAZ in Section 4.3.  
4.4.2 Results 
 The proliferation results for MCF10A and MDA.MB.231 cells exhibited very 
similar trends to that of YAP/TAZ nuclear localization. For MCF10A cells cultured on 1 
kPa substrates, high cell density significantly impaired proliferation (Figure 4-7a).  
Moreover, increasing the substrate stiffness shifted the proliferation curve toward higher 
cell densities (Figure 4-7b,c). Representative images of each condition are shown in 
Figure 4-7d. For MDA.MB.231 cells, increasing substrate stiffness also shifted the 
proliferation curve towards higher cell densities (Figure 4-8). We also found that the 
number of proliferating cells can be described by a Hill function of YAP/TAZ activity 
(Figure 4-9), which is in agreement with the transcriptional function of YAP/TAZ in 
regulating proliferation
125
. Therefore, the high degree of correlation between the 
proliferation marker Ki67 and YAP/TAZ nuclear fraction confirmed that YAP/TAZ 
nuclear fraction is representative of YAP/TAZ transcriptional activity.  
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4.5 Discussion 
 In cancer, the YAP/TAZ signaling pathway is often upregulated in high grade 
cancers, but upstream mutations are rare suggesting that the aberrant physical properties 
of the tumor microenvironment may contribute to its upregulation
182
. Therefore, to better 
understand the mechanisms underlying YAP/TAZ upregulation in cancer, we developed 
and experimentally validated a mathematical model of YAP/TAZ signaling that 
integrates ECM mechanosensing (via cytoskeletal tension) and cell-cell contact sensing 
(via Hippo signaling) pathways. The model predicts the YAP/TAZ nuclear fraction as a 
function of cell density and substrate stiffness for the non-cancerous cell line MCF10A 
(Figure 4-2) and the triple-negative breast cancer cell line MDA.MB.231 (Figure 4-5). 
The model also suggests that YAP/TAZ activation is regulated by a double-checkpoint 
that requires both inactivation of Hippo signaling and activation of cell-ECM 
mechanosensing. Furthermore, we found that inactivation of Hippo signaling with 
concomitant activation of cell-ECM mechanosensing is synergistic, and this synergy is 
especially pronounced in aggressive cancers that lack E-cadherin. Here, the synergy 
results from E-cadherin having a role in regulating both Hippo signaling and cytoskeletal 
tension (Figure 4-6).  
 Our work may also inspire further studies into how actin remodeling mediates 
crosstalk between cell-cell and cell-ECM interactions. Notably, we found that the 
remodeling of F-actin between non-cortical and cortical domains provides a mechanism 
by which cancer cells with hyper-active cytoskeletal tension can sense cell density. This 
mechanism helps to explain why tumor progression is enhanced by changing 
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microenvironmental mechanical properties. Importantly, our work demonstrates that this 
endogenous mechanosensing mechanism is still conserved in cancer.  
 The mathematical model can also be expanded to include additional proteins 
involved in the YAP/TAZ signaling cascade. For example, while we only considered 
Crumbs3 and Scribble when describing apical-basal polarity kinetics, additional apical-
basal polarity proteins, such as Merlin
182,200
 and Kibra
201
, can be incorporated as well.  
In summary, through integrating computational and experimental approaches, we 
have developed a mathematical model that is robust and can be used to study the precise 
mechanisms of YAP/TAZ regulation and their role in cancer. Ultimately, such an 
approach could be used to identify YAP/TAZ regulators amenable to chemotherapeutic 
intervention, and given the proposed role of YAP/TAZ in promoting CSC-like 
phenotypes
7,23
, metastasis
182
, and drug resistance
182
, it could lead to better clinical 
outcomes. 
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The YAP/TAZ computational signaling cascade is shown. The ECM mechanical 
properties are transduced into intracellular signals via adhesion molecules, such as FAK. 
Activation of FAK induces RhoA activity, which in turn activates both ROCK and mDia. 
Activation of ROCK leads to myosin activity and F-actin formation through the 
inhibition of Cofilin via limk. Moreover, the activation of mDia by RhoA also promotes 
F-actin formation. The resulting F-actin formation and myosin activity subsequently 
activate YAP/TAZ. The cell-cell contact sensing signaling pathway can inhibit 
YAP/TAZ activity through the Hippo signaling pathway core component LATS1/2 via 
Scribble and Crumb3 complexes. 
 
Figure 4- 1: The YAP/TAZ Signaling Pathway Network 
 86 
Specificity Source Catalog No. 
Application 
(Concentration) 
Mouse anti-TAZ/YAP Santa Cruz SC-101199 IF (1:100) 
Rabbit anti-Ki67 ThermoScientific PA5-16785 IF (1:100) 
Goat anti-mouse 
AlexaFluor 488 
ThermoScientific A11001 IF (1:500) 
Goat anti-Rabbit 
AlexaFluor 488 
ThermoScientific A27034 IF (1:500) 
 
Table 4-1: Antibody Information for Immunofluorescence Staining 
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Figure 4-2: MCF10A YAP/TAZ Nuclear Fraction as a Function of Cell Density and 
Substrate Stiffness 
The experimental and mathematical simulation results for MCF10A cells cultured on a) 1 
kPa collagen-coated polyacrylamide, b) 24 kPa collagen-coated polyacrylamide, and c) 
60 GPa collagen-coated glass. The mathematical simulation reflects the experimental 
data and shows that the curve for the YAP/TAZ nuclear fraction as a function of cell 
density shifts rightward with increasing substrate stiffness. The immunofluorescent 
images are shown for d) 1 kPa collagen-coated polyacrylamide, e) 24 kPa collagen-
coated polyacrylamide, and f) 60 GPa collagen-coated glass. The cellular nuclei are 
shown in red (BOBO-3 staining) and YAP/TAZ localization is shown in green. The 
localization of YAP/TAZ to the nucleus represents its activity. The scale bars are 10 µm.  
  
 88 
 
Figure 4-3: Mathematical Results for MCF10A YAP/TAZ Nuclear Fraction as a 
Function of Cell Density and Substrate Stiffness 
The mathematical results for MCF10As reveal that a) increasing substrate stiffness 
causes a rightward shift in the curve of YAP/TAZ nuclear fraction versus cell density. 
Moreover, at low cell densities, increasing substrate stiffness increases the YAP/TAZ 
nuclear fraction. b) Increasing cell density causes a downward shift in the curve of 
YAP/TAZ nuclear fraction versus substrate stiffness. Notably, at very dense cellular 
densities, the YAP/TAZ nuclear fraction is almost exclusively cytosolic even at high 
substrate stiffnesses.  
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Figure 4-4: Mathematical Model Representing Shifts in Cortical and Non-cortical F-
actin as a Function of Cell Density ad Substrate Stiffness 
The mathematical model predicted shifts in a) non-cortical and cortical F-actin as a 
function of cell density and substrate stiffness. Here, increasing cell density caused a shift 
from non-cortical F-actin to cortical F-actin. Moreover, increasing substrate stiffness 
increased the percentage of actin in the non-cortical domain within both ‘sparse’ and 
‘confluent’ seeding densities. b) Immunofluorescent staining of F-actin at low cell 
densities (left) and high densities (right) supported our mathematical model as cells 
within the dense condition exhibited a thicker cortex and fewer stress fibers. The scale 
bars are 10 µm.  
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Figure 4-5: MDA.MB.231 YAP/TAZ Nuclear Fraction as a Function of Cell Density 
and Substrate Stiffness 
The experimental and mathematical simulation results for MDA.MB.231 cells cultured 
on a) 1 kPa and 24 kPa collagen-coated polyacrylamide. The mathematical simulation 
reflects the experimental data and shows that the curve for the YAP/TAZ nuclear fraction 
as a function of cell density shifts rightward with increasing substrate stiffness. The 
immunofluorescent images are shown for b) 1 kPa and 24 kPa collagen-coated 
polyacrylamide. The cellular nuclei are shown in red (BOBO-3 staining) and YAP/TAZ 
localization is shown in green. The localization of YAP/TAZ to the nucleus represents its 
activity. The scale bars are 10 µm.   
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Figure 4-6: Mathematical Results for MDA.MB.231 YAP/TAZ Nuclear Fraction as 
a Function of Cell Density and Substrate Stiffness 
The mathematical results for the triple negative breast cancer cell line MDA.MB.231 
reveal that a) increasing substrate stiffness causes a rightward shift in the YAP/TAZ 
nuclear localization curve toward higher cell densities. Moreover, the YAP/TAZ nuclear 
fraction remains relatively high even on 1 kPa substrates, indicating that the basal level of 
YAP/TAZ activity is higher for MDA.MB.231 cells compared to MCF10A cells. In 
addition, b) increasing cell density inhibited YAP/TAZ nuclear fraction, demonstrating 
that YAP/TAZ activity is still inhibited at high cell densities within MDA.MB.231 cells.  
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Figure 4-7: MCF10A Proliferation as a Function of Cell Density and Substrate 
Stiffness 
The proliferation marker Ki67 was used to assess MCF10A cellular proliferation on a) 1 
kPa collagen-coated polyacrylamide, b) 24 kPa collagen-coated polyacrylamide, and c) 
60 GPa collagen-coated glass. The results of the mathematical simulations (red line) are 
plotted with experimental data (black dots). d) Representative immunofluorescent images 
of Ki67 are shown. The cell nuclei are shown in red (BOBO-3) and Ki67 is shown in 
green. The scale bars are 10 µm.  
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Figure 4-8: MDA.MB.231 Proliferation as a Function of Cell Density and Substrate 
Stiffness 
The proliferation marker Ki67 was used to assess MDA.MB.231 cellular proliferation on 
a) 1 kPa and b) 24 kPa collagen-coated polyacrylamide. The results of the mathematical 
simulations (red line) are plotted with experimental data (black dots). c) Representative 
immunofluorescent images of Ki67 are shown. The cell nuclei are shown in red (BOBO-
3) and Ki67 is shown in green. The scale bars are 10 µm.  
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Figure 4-9: The Proliferation Marker Ki67 and YAP/TAZ Nuclear Fraction Are 
Highly Correlated within MCF10A and MDA.MB.231 Cells 
The percentage of cells that stained positive for the proliferation marker Ki67 is highly 
correlated with YAP/TAZ nuclear fraction for both a) MCF10A and b) MDA.MB.231 
cells. Notably, the correlation between Ki67 and YAP/TAZ is observed for all substrate 
stiffnesses.   
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CHAPTER 5. Designing of a 3D In Vitro PEG/Collagen Interpenetrating Network 
(IPN) for the Study of Mechanotransduction 
5.1  Introduction 
 In two-dimensional studies, hydrogels such as polyacrylamide offer the capacity 
to investigate individual biophysical parameters independently; for example, the effect of 
substrate stiffness on cellular behavior can be separated from ligand composition and 
ligand density
84,202–204
. For 3D cell culture systems, however, the physical parameters of 
stiffness, ligand composition, and ligand density become more entangled and difficult to 
decouple. Despite this, a significant effort has been made to decouple them with studies 
involving synthetic polymeric biomaterials
9,10
, naturally-derived biomaterials
205,206
, and 
combinations of the two
207,208
.  
 For purely synthetic polymeric biomaterials, cells are typically encapsulated 
within hydrogels
209,210
. Such an approach has the advantage of being highly tunable, often 
with elastic moduli spanning several orders of magnitude, but suffers from a lack of 
natural cell-adhesion sites and an inability to be remodeled by cells. To overcome this, 
cell-adhesion peptides
211–213
 and protease-degradable peptide linkers
10,214–216
 are often 
incorporated into the network. While the incorporation of these peptides increases the 
bioactivity of the material, it still does not completely recapitulate the rich bioactivity and 
topography of full-length proteins. In addition, most studies only incorporate the cell-
adhesion peptide sequence RGDS, which has been shown to interact with a limited set of 
integrins and therefore may not completely mimic all cell-matrix interactions present in 
vivo
217
.  
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 Naturally-derived biomaterials can be organized into two classes: 1) 
polysaccharide-based materials (i.e. alginate
218
, hyaluronic acid
219
, chitin/chitosan, and 
starch) that have highly tunable mechanical properties, but little to no inherent 
bioactivity; and 2) protein-based materials (i.e. collagen, reconstituted basement 
membrane, and fibrin) that possess inherent bioactivity, but have poor mechanical 
properties. Therefore, efforts have been made to improve the mechanical properties of 
protein-based materials; for example, with 3D collagen, the elastic moduli can be 
increased by crosslinking with glutaraldehyde, ribose, or tissue transglutaminase
220
. 
However, each of these approaches has their limitations as glutaraldehyde is 
cytotoxic
221,222
, ribose yields a limited elastic moduli range between 100 and 150 Pa
61
, 
and tissue transglutaminase alters pore size
223,224
.  
 A promising alternative to purely synthetic or purely naturally-derived materials 
is an interpenetrating network (IPN). Here, a primary network consisting of a protein-
based naturally-derived material is reinforced with a secondary polymeric network, 
resulting in a material possessing both inherent bioactivity, from the naturally-derived 
component, and tunable mechanical properties, from the synthetic component.  
In cancer biology, IPNs have been used to study mechanotransduction for over a 
decade. An early in vitro 3D cancer mechanotransduction study used an IPN composed of 
reconstituted basement membrane (rBM) (also known as Matrigel) and collagen, and 
revealed that increasing the overall stiffness of the environment by increasing the 
collagen concentration led to a more malignant phenotype
3
. However, increasing the 
collagen concentration also increases both stiffness and ligand density, and increasing 
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ligand density has been shown to activate distinct signaling pathways independent of 
stiffness
225–227
. In another study, a primary collagen type-I network was reinforced with a 
secondary network composed of agarose
228
. The addition of agarose significantly 
increased the mechanical properties of the collagen by several orders of magnitude 
without substantially altering the collagen fiber organization. Moreover, the agarose 
created an environment that physically constrained the embedded cells and elicited a 
switch from mesenchymal- to amoeboid-type migration. However, agarose-based 
systems cannot be degraded by cells, which precludes them from being used to study 
cell-mediated ECM remodeling
229
.   
 An additional area of research has been to reinforce naturally-derived protein 
networks with a secondary network composed of naturally-derived polysaccharides. To 
this end, a highly tunable material composed of rBM and alginate has been 
developed
66,205
. Alginate is a cytocompatible and biologically inert polysaccharide 
derived from seaweed and consists of blocks of mannuronic and guluronic acid
218
. The 
stiffness of the alginate network can be tuned by altering the concentration of divalent 
cations, such as calcium (Ca
2+
), which form ionic crosslinks between neighboring blocks 
of guluronic acid
230
. Notably, not only can the elastic properties of the material be tuned, 
but viscous properties can be tuned as well, thereby providing a powerful in vitro tool to 
study the effect of complex visco-elastic properties on cellular behavior. However, 
whether this approach is applicable to other ECM proteins besides amorphous rBM is 
unclear. For fibrous collagen networks, the positively charged divalent cations necessary 
for alginate crosslinking may interfere with collagen formation as the ionic strength of 
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the neutralizing buffer has been shown to affect collagen fiber organization
231,232
.  
An alternative collagen type I-based IPN system has recently been developed 
involving gelatin-methacrylate
208
. Gelatin is a denatured form of collagen type-I that 
retains some of collagen’s original bioactivity. Importantly, gelatin can be functionalized 
with methacrylate groups to form photopolymerizable hydrogels containing covalent 
crosslinks, which affords spatiotemporal control of polymerization and yields a material 
with highly tunable mechanical properties
233,234
. In the aforementioned study involving 
an IPN composed of collagen type-I and gelatin-methacrylate, the authors were able to 
tune the shear modulus of their material between 2 and 12 kPa without significantly 
disrupting collagen fiber organization. With this approach, increasing IPN stiffness 
independent of fiber density was found to significantly impair invasion of MDA.MB.231 
spheroids. However, while this novel approach provides an important tool for decoupling 
the effects of stiffness and fiber density within collagen type-I networks, the residual 
bioactivity present within gelatin may hinder its applicability to the study of other cellular 
microenvironments, such as the embryonic stem cell niche
235
 or the hair follicle adult 
stem cell niche
236
, where collagen type-I is not abundantly present.  
Therefore, there is still a need for a robust system that can be used to study 
multiple ECM protein networks while also affording highly tunable mechanical 
properties. Here, we sought to develop such a system by reinforcing a collagen type-I 
network with a secondary polymeric network composed of poly(ethylene glycol) (PEG). 
We hypothesized that by delivering soluble monomers to a cell-laden collagen network, 
we could crosslink these monomers in situ via photopolymerization to form a secondary 
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interpenetrating polymeric network. We believed this approach would enable us to 
maintain collagen fiber organization while also providing us with the ability to 
independently tune the mechanical properties of the overall network.  
5.2  Initial Polymeric Scaffold Design Selection 
 To design our IPN, we sought polymeric networks that fit the following criteria: 
ability to 1) form networks from monomers capable of readily diffusing into cell-laden 
3D collagen gels, 2) provide spatiotemporal control of crosslinking, 3) generate a stable 
secondary network upon crosslinking, and 4) have a limited effect on cell viability.  
To achieve these design specifications, we investigated two polymeric systems 
that form networks from monomers with relatively low molecular weights, and thus 
possessed desirable diffusion properties. The first system contained monomers of the 
zwitterionic 2-methacryloyloxyethyl phosphorylcholine (MPC) with ethylene glycol 
dimethacrylate (EGDMA) as a crosslinker, shown in Figure 5-2. The second system 
utilized thiol-ene “click” chemistry and consisted of 4-arm poly(ethylene glycol) 
monomers functionalized with norbornene (PEG4NB) and linear poly(ethylene glycol) 
dithiol (PEGdithiol) as a crosslinker, shown in Figure 5-3.  
5.2.1 MPC and EGDMA Network Chemistry 
The MPC/EGDMA approach uses a chain-growth free-radical polymerization 
reaction, and was inspired by a tissue-supplementing technique used to restore the 
mechanical properties of osteoarthritic cartilage to that of healthy cartilage
237
. MPC is a 
zwitterionic monomer with no net molecular charge, but possesses a negatively charged 
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phosphate group and a positively charged trimethylammonium group, which enables it to 
have a high degree of hydration. In addition, MPC has been shown to be 
cytocompatible
238,239
 and can generate 3D networks with elastic moduli over several 
orders of magnitude
240,241
.  
5.2.2 PEGnorbornene and PEGdithiol Network Chemistry 
“Click” chemistries are a family of chemical reactions that are fast, specific, and 
high yielding
242,243
. Furthermore, a subset of them have been used in 3D cell culture 
systems as they proceed under mild conditions, exhibit few or no side products, 
polymerize in the presence of oxygen, generate homogeneous networks, and are 
considered bio-orthogonal
244
. These aforementioned characteristics offer several 
advantages over acrylate- or methacrylate-based free-radical polymerization reactions, 
which have been shown to be inhibited by oxygen and produce heterogeneous 
networks
245
. 
For this work, we investigated the “click” reaction known as thiol-ene, which 
proceeds via a radical-mediated step-growth mechanism that can be initiated by any free 
radical source. The reaction mechanism is shown in Figure 5-4 and occurs as a result of 
the addition of thiol functional groups across carbon-carbon double bonds, also known as 
‘enes’. The reaction propagates via alternations between addition and chain transfer 
reactions: first, the thiyl radical adds across the carbon-carbon double bond to form a 
carbon radical; second, the resulting carbon radical abstracts a hydrogen from an 
additional thiol functional group; and finally, the abstraction of a hydrogen results in an 
additional thiyl radical and the reaction proceeds. The step-growth mechanism results in a 
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1:1 stochiometric consumption of thiol to ene functional groups. In addition, the step-
growth mechanism causes the molecular weight of the system to increase slowly until 
gelation is achieved resulting in a homogeneous network
245
. For the IPN system 
developed in this study, the functional group norbornene was chosen because it is ring 
strained and thus highly reactive
245
.  
5.2.3 Cytocompatibility Testing of Photoinitiators 
 Spatiotemporal control over the reaction is highly desirable for our system as it 
allows the soluble monomers to fully diffuse into the cell-laden collagen gels prior to the 
initiation of crosslinking. Moreover, photoinitiators afford a high degree of 
spatiotemporal control and were therefore explored as potential crosslinking mechanisms.   
Only a few photoinitiators are considered cytocompatible, which include Irgacure 
2959 (I-2959), lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP), and Eosin Y
246–
249
. I-2959 and LAP are Type I photoinitiators that readily absorb photons and decompose 
into two primary radicals to initiate crosslinking
250,251
. While these photoinitiators are 
commonly used, each requires UV light to initiate crosslinking, which raises concerns 
over DNA damage and long-term cell viability. In contrast, Eosin Y is a Type II initiator 
which can initiate crosslinking with visible light and overcomes the concerns associated 
with UV crosslinking. However, Type II photoinitiators require a co-initiator because 
their mode of action involves abstracting a hydrogen atom from the coinitiator in order to 
generate secondary radicals that in turn initiate crosslinking
249
. Importantly, in order to 
efficiently crosslink methacrylate systems, such as is the case with our MPC/EGDMA 
system, Eosin-Y requires the use of triethanolamine (TEOA) as the coinitiator and 1-
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vinyl-2 pyrrolidinone (NVP) as a comonomer
237
. But notably, thiol-ene systems, such as 
our PEG4NB and PEGdithiol system, do not require coinitiators because the excitation of 
Eosin Y by visible-light exposure extracts a hydrogen from the sulfihydryl group on the 
PEGdithiol and creates thiyl radicals that in turn initiate crosslinking
249
. 
5.2.3a Materials and Methods 
To evaluate the cytocompatibility of the three aforementioned photoinitiators (I-
2959 (Sigma-Aldrich), LAP (Tokyo Chemical Industry Co.), and Eosin Y (Sigma-
Aldrich)), the co-initiator TEOA (Sigma-Aldrich), and the comonomer NVP (Sigma-
Aldrich); MDA-MB-231 cells were first encapsulated within 2 mg/mL collagen gels at a 
seeding density of 100,000 cells/mL on a glass-bottom 96-well plate (Mattek); gel 
dimensions measured 5 mm in diameter by 1 mm thick. After 24 hours, the 
photoinitiators were administered to the cell-laden collagen gels and incubated for 16 
hours in the absence of light. We chose a 16 hr period of incubation because we believed 
it provided more than enough time for the monomers to reach diffusive equilibrium 
within the collagen gels. Following the 16 hr incubation with the photoinitiators, the 
photoinitiator solution was removed and the collagen gels were washed 3x’s with media 
(45 minutes between washes). The cell-laden gels were then allowed to recover for an 
additional 16 hrs, at which point cell viability was assessed using the commercially 
available LIVE/DEAD assay (ThermoScientific).  
To ascertain the percentage of viable cells, confocal stacks (500 µm tall stacks 
with a 10 µm interval between images) were acquired and subsequently analyzed using 
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ImageJ. The number of viable cells versus dead cells was counted manually using 
ImageJ’s cell counter plug-in. To avoid bias, the image stacks were randomized.  
5.2.3b Results 
 The viability tests revealed I-2959, LAP, and Eosin Y to be cytocompatible well 
within their working concentrations, as shown in Figure 5-5. However, both the 
coinitiator TEOA and the comonomer NVP displayed significant cytotoxicity at their 
working concentrations, indicating that TEOA and NVP may not be suitable for our IPN 
platform. 
5.2.4 Cytocompatibility Testing of Soluble Monomers 
 The approach to forming IPNs undertaken in this work requires that the soluble 
form of the monomers be cytocompatible for at least the period of time necessary for the 
monomers to fully diffuse into the collagen gel, at which point the network can be 
crosslinked. Therefore, the cytocompatibility of the monomers were investigated.  
5.2.4a Materials and Methods 
To evaluate the cytocompatibility of the monomers in their soluble form, a 
LIVE/DEAD assay was performed on MDA-MB-231 cells encapsulated within 3D 
collagen gels following treatment with either MPC (Sigma-Aldrich; MW 295.3 D), 
EGDMA (Sigma-Aldrich; MW 0.198 D), poly(ethylene glycol) dimethacrylate 
(PEGDMA) (Sigma-Aldrich; MW 750 D), PEG4NB (Sigma-Aldrich; MW 10 kD), or 
PEGdithiol (Sigma-Aldrich; MW 3.4 kD). The procedure to evaluate cytocompatibility 
followed the same method as described in section 5.2.3b.  
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5.2.4b Results 
 The results of the monomer cytocompatibility tests revealed that MPC is 
cytocompatible at concentrations as high as 200 mM (Figure 5-6a), but the crosslinker 
EGDMA began to display significant cell death at a concentration of 1.69 mM as its 
viability was found to be 80.4 ± 3.9% (Figure 5-6b). Interestingly, the crosslinker 
PEGDMA (Mn = 750 D), which has approximately 12 repeating ethylene glycol units 
within it, did not exhibit the same degree of cell death at 1.69 mM as the EGDMA 
condition. In contrast, its viability was found to be 91.9 ± 1.9% (Figure 5-6c). These 
results suggest that crosslinkers with higher molecular weights may be less cytotoxic.  
 For the PEG4NB/PEGdithiol system, cell viability was found to not be 
statistically different from the control condition for all monomer concentrations tested 
(Figure 5-7), therefore indicating that this system may be suitable for our IPN platform. 
5.2.5 Selecting the Polymeric Network Chemistry 
 After evaluating the cytocompatibility of each component within both the 
MPC/EGDMA and PEG4NB/PEGdithiol systems, the ability to form networks was 
investigated using monomer concentrations that were within each monomer’s respective 
cytocompatibility concentration range. To test network formation during these 
preliminary tests, the polymer solution was pipetted following irradiation. Here, fully 
formed networks would appear solid-like, which meant that they could not be pipetted, 
while unformed networks remained liquid and could be pipetted. While this test was 
simple, it enabled us to qualitatively assess network formation in a relatively quick 
manner.  
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 For the MPC/EGDMA system, a pre-polymer solution was made containing 170 
mM MPC, 1 mM EGDMA, and 0.1 wt% of I-2959, and exposed to 365 nm light (~2 mW 
cm
-2
) from a Pierce 3UV lamp (ThermoScientific). Despite irradiating for as long as 30 
min, network formation was not observed. Increasing the monomer concentrations within 
the pre-polymer solution to 575 mM MPC and 7 mM EGDMA generated crosslinked 
networks, but the monomer concentrations were well above acceptable cytocompatible 
levels. In contrast, the PEG4NB/PEGdithiol system yielded more promising results. Here, 
a pre-polymer solution containing 10 mM PEG4NB, 20 mM PEGdithiol, and 0.1 wt% I-
2959 was exposed to 365 nm light for 5 minutes and formed a crosslinked 3D network.  
 The tests revealed the PEG4NB/PEGdithiol system to be superior to the 
MPC/EGDMA system, as exhibited by higher cytocompatibility and better network 
formation. The results also illustrate the limitations of using chain-growth free-radical 
polymerization reactions for 3D cell culture systems: mainly that these reactions require 
high polymer concentrations; can cause cell death through the generation of a large 
number of free-radicals
252
; and are inhibited by oxygen molecules
253
, which must be 
present within cell culture systems. However, the thiol-ene chemistry overcomes these 
limitations as the step-growth mechanism requires lower polymer concentrations, 
generates fewer free-radicals, and can proceed even in the presence of oxygen
245
.  
Importantly, visible-light-mediated Eosin Y photoinitiation, without the addition of 
potentially cytotoxic coinitiators and comonomers, can be used with 
PEG4NB/PEGdithiol due to its unique step-growth mechanism
249
. Therefore, the 
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PEG4NB/PEGdithiol system was selected for the polymeric scaffold and consequently 
further investigated. 
5.3 Design Optimization of PEG4NB/PEGdithiol System 
 The PEG4NB/PEGdithiol system is able to generate materials with highly tunable 
mechanical properties so the next focus of IPN development was to optimize the 
composition of the PEGnorbornene/PEGdithiol system. Here, three parameters of the 
polymeric system can be tuned: 1) overall polymer concentration, 2) crosslinker length, 
and 3) the molar ratios of enes to thiols. 
5.3.1 Investigating PEG4NB:PEGdithiol Molar Ratios 
 In an ideal step-growth network, the stoichiometric consumption of ‘enes’ to 
‘thiols’ is 1:1, and is represented by the Flory-Stockmayer equation254: 
𝛼 =  √
1
𝑟(𝑓𝑡ℎ𝑖𝑜𝑙−1)(𝑓𝑒𝑛𝑒−1)
  (5-1) 
where α represents the gel point conversion, r represents the molar ratio of thiol to ene 
functional groups, fthiol is the thiol monomer functionality (for PEGdithiol this is equal to 
2), and fene is the ene monomer functionality (for PEG4NB this is equal to 4). In an ideal 
step-growth network, molar ratios that yield a gel point conversion (α) value less than 1 
will produce crosslinked networks. Table 5-1 depicts theoretical α values as a function of 
molar ratio for the PEG4NB/PEGdithiol network.  
 The Flory-Stockmayer calculations predicted that a monomer solution containing 
a 1:2 molar ratio of PEG4NB:PEGdithiol would form a network with the greatest degree 
of crosslinking. This prediction was experimentally validated as a 1:2 molar ratio of 
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PEG4NB:PEGdithiol readily formed networks, but 1:4 and 1:1 molar ratios did not. For 
these experiments, the PEG4NB concentration was kept constant at 10 mM while the 
concentration of PEGdithiol was changed to the desired molar ratio. Additionally, the 
system was crosslinked with 0.1 mM of the photoinitiator Eosin Y and irradiated with 
green laser light (514 nm; 500 mW cm
-2
) for 120 seconds. From these observations, a 
constant 1:2 molar ratio of PEG4NB:PEGdithiol was therefore used for the rest of the 
study. 
5.3.2 Investigating the Effect of PEGdithiol Crosslinker Length on Network Properties 
 As crosslinker length has been shown to affect network mechanical properties, we 
investigated the effect of three PEGdithiol crosslinkers, with differing molecular weights 
(0.154 kD, 1.0 kD, and 3.4 kD), on network mechanics and cell viability.  
5.3.2a PEGdithiol Crosslinker Viability Testing 
 The cytocompatibilities of PEGdithiol crosslinkers with differing molecular 
weights were investigated using MDA.MB.231 cancer cells embedded within 3D 
collagen gels, as previously described in Section 5.2.4. Here, cells were incubated with 
solutions containing PEGdithiol (0.154 kD, 1.0 kD, and 3.4 kD)—the 0.154 kD 
crosslinker is also commonly referred to as dithiothreitol (DTT))—for 16 hrs, at which 
point the solutions were removed and a LIVE/DEAD assay was performed according to 
the procedure depicted in Section 5.2.4.  
 The viability results revealed the lower molecular weight PEGdithiol crosslinkers 
to have a negative effect on cell viability, while the 3.4 kD PEGdithiol showed no 
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discernable effects (Figure 5-8). Interestingly, the viability results of PEGdithiol showed 
the same trend as EGDMA and PEGDMA, providing further evidence that there is an 
inverse relationship between crosslinker length and cytotoxicity. 
 The cytocompatibility of the lower molecular weight PEGdithiol crosslinkers 
were then further characterized by investigating the viability of collagen-embedded 
MDA.MB.231 following varying lengths of PEG crosslinker incubation time. Here, the 
0.154 kD and 1.0 kD MW PEGdithiol crosslinkers were investigated, and administered to 
collagen-embedded MDA.MB.231 cells for 1, 4, 8, 12, and 16 hours. Varying the time 
duration revealed that 1.0 kD PEGdithiol does not significantly affect cell viability until 
12 hours of incubation for the 20 mM and 40 mM concentrations (Figure 5-9a-b). 
However, the 0.154 kD exhibited a significant decrease in viability for an incubation time 
as short as 4 hours, further highlighting the greater cytotoxicity displayed by relatively 
short crosslinkers (Figure 5-9c-d).  
5.3.2b Mechanical Testing of PEG Networks as a Function of PEGdithiol Molecular 
Weight 
 To determine the effect of PEGdithiol crosslinker length on network mechanical 
properties, the elastic moduli of PEG hydrogels composed of 10 mM PEG4NB, 20 mM 
PEGdithiol (0.154 kD, 1.0 kD, and 3.4 kD) and crosslinked with visible light (514 nm; 
500 mW cm
-2
) for 120 seconds using 0.1 mM Eosin Y were measured using the 
displacement-controlled Piuma nanoindentation system (Optics11, Netherlands). 
Nanoindentation was chosen as the method for mechanical testing because it allowed us 
to test fully-hydrated samples and did not require large sample volumes.  
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Here, cylindrical PEG hydrogels were formed by sandwiching a 10 µL droplet of 
monomer solution between a 24-well glass-bottom dish (Mattek) and a 10 mm diameter 
round glass coverslip. To covalently attach the PEG hydrogel to the glass-bottom dish, 
the glass surface was first functionalized by treating with BIND-silane solution 
containing 0.3% (vol/vol) of 3-(trimethoxysilyl)propyl methacrylate (Sigma-Aldrich) in 
5% (vol/vol) acetic acid (glacial) and 95% (vol/vol) ethanol for 30 min. To prevent PEG 
hydrogel attachment to the round coverslip, the coverslip was treated with 
dichlorodimethylsilane. After the polymer solution was crosslinked with visible light, the 
PEG hydrogel was allowed to swell in PBS overnight prior to mechanical testing.  
For the nanoindentation tests, a spherical probe with a radius of 20.5 µm and a 
cantilever stiffness of 0.105 N/m was indented into a given PEG hydrogel surface at a 
constant rate of 10 µm/s. The reduced elastic moduli of the PEG hydrogels were then 
calculated using Hertz contact theory with the assumption that the PEG hydrogel material 
was elastic and isotropic
255
. Importantly, the elastic modulus was calculated on the 
loading portion of the load-displacement curve, which has been shown to be more 
suitable for soft, hydrated materials
256,257
. The results from the mechanical tests are 
shown in Figure 5-10. Each PEGdithiol condition consisted of 3 individual gels with 5 
indentations per gel, separated by more than 500 µm to avoid material creep effects. 
The nanoindentation tests showed that the 0.154 kD, 1.0 kD, and 3.4 kD 
PEGdithiol hydrogel networks have elastic moduli of 19.0 ± 1.74, 4.2 ± 1.4, and 1.0 ± 0.1 
kPa, respectively. These results reveal an inverse relationship between crosslinker 
molecular weight and hydrogel network elastic modulus, and are consistent with other 
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studies showing that hydrogel networks containing shorter crosslinkers have smaller pore 
sizes and are therefore mechanically stiffer
258,259
. 
5.3.2c Conclusions from Investigating PEGdithiol Crosslinker Molecular Weight 
 The viability and nanoindentation mechanical testing revealed a trade-off between 
viability and hydrogel stiffness: shorter PEGdithiol crosslinkers generate stiffer gels, but 
are more cytotoxic; however, longer PEGdithiol crosslinkers are less cytotoxic, but 
generate softer gels. Therefore, selecting the appropriate PEGdithiol crosslinker length 
for the PEG/Collagen IPN platform required balancing these properties. Furthermore, 
because the PEGdithiol crosslinker cytotoxicity was found to be time-dependent, we 
hypothesized that decreasing the monomer incubation time to less than 16 hours might 
allow us to use a shorter crosslinker, which could provide us with stiffer hydrogels 
without significant cytotoxic effects.  We therefore sought to estimate the diffusion 
coefficients of the PEG monomers, and modeled the diffusion kinetics of the PEG 
monomers diffusing into 3D collagen gels with the hope that we could determine the 
minimal amount of time required to reach diffusive equilibrium in our IPN system.  
5.3.3 Finite Element Modeling of PEG Monomer Diffusion into 3D Collagen Gels 
 Modeling the diffusion of PEG monomers into collagen required two steps: 1) 
identifying the diffusion coefficients of PEG monomers as a function of both molecular 
weight and shape (e.g. linear vs. branched monomers), and 2) developing a finite element 
model in COMSOL Multiphysics (COMSOL Inc. Palo Alto, USA). 
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 The diffusion coefficients of the PEG monomers were estimated based on 
experimental measurements taken by Wang et al. (2010)
260
. In this work, the 
hydrodynamic radius (Rh) of both linear and branched PEG monomers were measured as 
a function of average number molecular weight (Mn) using pulsed-gradient spin-echo 
NMR spectroscopy and the Stokes-Einstein equation. Linear PEG monomers, with 
average number molecular weights ranging from 600 to 8,000 D, were studied and the 
results are shown in Figure 5-11a. In addition, branched 4-arm PEG monomers, with 
average number molecular weights ranging from 1,000 to 10,000 D, were also studied 
and the results are shown in Figure 5-11b. The relationship between Mn and Rh is 
relatively linear when plotted in a log-linear manner, which enabled the Rh of the PEG 
monomers in our study to be estimated, as shown in Table 5-2. Moreover, the diffusion 
coefficient for each monomer was calculated using the Stokes-Einstein equation: 
𝐷0 =  
𝑘𝐵𝑇
6𝜋𝜂𝑅ℎ
  (5-2) 
where D0 is the diffusion coefficient in water, kB is Boltzmann’s constant, T is 
temperature, η is viscosity, and Rh is hydrodynamic radius. The calculated diffusion 
coefficients are shown in Table 5-2.  
 In addition, we considered the effect of collagen networks on diffusion behavior. 
Notably, Ramanujan et al. (2002) used FRAP and tracer particles of varying Rh to 
investigate the diffusion coefficient ratio (D/D0) within collagen gels ranging from 2.4 
mg/mL to 45 mg/mL as a function of hydrodynamic radius (Figure 5-12). For the 2 
mg/mL collagen gels, D/D0 was estimated to be equal to 0.90 and the calculated Dcollagen 
for each monomer is shown in Table 5-2.  
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 With the diffusion coefficients for each monomer estimated, a diffusion model 
was created in COMSOL Multiphysics. Here, the geometry of the collagen gels (a 
cylinder 10 mm in diameter and 1 mm thick) was recreated using axi-symmetric 
symmetry. The PEG concentration as a function of time and z-position within the 
collagen gel was simulated and the results are shown in Figure 5-13.  
 The COMSOL finite element model demonstrated that for the largest monomer, 
PEG4NB (10 kD), PEG monomer diffusive equilibrium should be reached within 6 hrs. 
Importantly, as a result of this model, the 16 hr incubation time was determined to be 
excessive and replaced by a 6 hr incubation period, which meant that the 1.0 kD 
PEGdithiol crosslinker could be used for the IPN platform as it had previously been 
shown to have a negligible effect on cell viability for incubations less than 8 hrs.   
5.3.4 The Finalized PEG Monomer Composition 
 Based on the results from the cytocompatibility assays, nanoindentation tests, and 
our finite element model, the final PEG monomer composition was selected to be 
PEG4NB (10 kD) and PEGdithiol (1.0 kD), in a constant 1:2 molar ratio, and crosslinked 
with visible light (514 nm, 500 mW cm
-2
) for 120 seconds using 0.1 mM Eosin Y as the 
photoinitiator. Moreover, the finalized experimental workflow for the IPN platform is 
depicted in Figure 5-14 and consisted of the following: 1) embedding cells within 3D 
collagen gels and allowing them to adhere for 24 hours, 2) adding the soluble polymer 
solution and allowing 6 hours for the polymer to fully diffuse into the collagen gel, 3) 
removing the excess polymer solution and irradiating with visible light to initiate 
crosslinking, 4) washing 3x’s with cell culture media to remove any uncrosslinked 
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monomers, and 5) adding a final volume of cell culture media to the IPN and proceeding 
to perform the experiment of interest. 
5.4 Material Characterization of PEG/Collagen IPNs 
 After the composition of the PEG network had been finalized, the material 
properties of PEG/Collagen IPNs were characterized by investigating IPN microstructure, 
biomolecular transport behavior, and mechanical properties. 
5.4.1  IPN Microstructure via Scanning Electron Microscopy (SEM) 
 Investigating the microstructures of PEG/Collagen IPNs was of interest because 
PEG and collagen networks have different length scales; pure collagen networks have 
pore sizes on the order of a few micrometers
261
, while pure polymeric hydrogels typically 
have pore sizes on the order of nanometers
262,263
. Here, the microstructures of 
PEG/Collagen IPNs were examined using scanning electron microscopy.  
5.4.1a Materials and Methods 
 PEG/Collagen IPNs, without embedded cells, were formed using the method 
provided in Section 5.3.4. Here, the collagen concentration was 2 mg/mL and the 
concentrations of PEG monomers were 10 mM PEG4NB and 20 mM PEGdithiol (1.0 
kD). In addition, pure 2 mg/mL collagen gels and pure PEG gels were formed as controls. 
After the collagen, PEG/Collagen, and PEG gels were formed, the gels were allowed to 
swell in PBS overnight.  
 After swelling overnight, the samples were prepared for SEM imaging using a 
modified approach based on a previously described technique
205,264
. Briefly, samples 
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were serially transitioned into absolute methanol by first incubating the samples for 30 
min in 35, 50, 70, 90, and 100% ethanol. Then, two 30 min incubations with 100% 
methanol were performed. The methanol dehydrated samples were dried in a critical 
point dryer and adhered onto sample stubs using carbon tape. Samples were coated with 5 
nm of platinum-palladium and imaged using a Carl Zeiss Supra 55 VP Field Emission 
Scanning Electron Microscope. 
5.4.1b SEM Results 
 The images obtained from SEM imaging are shown in Figure 5-15. The 2 mg/mL 
collagen condition showed a highly porous and fibrous microstructure (Figure 5-15a), 
while the addition of the secondary PEG network in the PEG/Collagen IPN condition 
yielded a much less porous microstructure (Figure 5-15b). For the pure PEG network, the 
gel appeared as a continuous surface (Figure 5-15c) due to its pore size being on the order 
of nanometers.  
 The SEM images were analyzed by generating histograms of pixel-intensity for 
each condition. The histogram for the collagen condition (Figure 5-15d) displayed a left-
shifted curve, reflecting the microstructure being highly porous and heterogeneous. 
Interestingly, the histogram for the PEG/Collagen condition (Figure 5-15e) appeared to 
be more normalized, indicating that the secondary PEG network created a less porous and 
more homogeneous microstructure. Moreover, the histogram for the pure PEG condition 
(Figure 5-15f) showed a narrow peak and illustrates a very homogeneous network 
microstructure. 
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5.4.2 Biomolecular Transport Properties of PEG/Collagen IPNs 
The SEM imaging revealed differences in microstructure between the collagen 
and PEG/collagen IPNs, which led us to hypothesize that these differences in 
microstructure might affect the diffusion of biomolecules within the networks. Therefore, 
we sought to further characterize the networks by measuring the diffusion coefficient of 
tracer molecules within each network.  
5.4.2a Materials and Methods 
 To characterize the molecular transport properties within the PEG/Collagen IPN 
platform, we modified a technique that had previously been used to measure the diffusion 
of fluorescently-labeled BSA within 3D alginate gels
66,206
. The previous approach 
sandwiched alginate gels between a 24-well plate and the bottom of a 24 transwell-insert, 
and measured the diffusion of fluorescently-labeled BSA into a PBS solution located in 
the top of the transwell. While this approach may have been effective for 3D alginate 
gels, it was difficult to use with 2 mg/mL collagen gels because the collagen gels are 
much softer and often detached from the bottom surface of the transwell. To overcome 
this, we formed our gels in the top of the insert and measured the diffusion of our tracer 
molecules into the bottom of the transwell. The experimental setup is illustrated in Figure 
5-16.  
 With our approach, we measured the diffusive properties of two molecules—the 
small molecule Irgacure 2959 (Sigma-Aldrich) with a molecular weight of 0.224 kD, and 
bovine serum albumin (BSA) labeled with AlexaFluor 594 (BSA-AlexaFluor 594, 
Invitrogen) and having a molecular weight of 66.6 kD—within collagen and 
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PEG/Collagen networks. I-2959 was selected because it is affordable and strongly 
absorbs light at wavelengths less than 365 nm, which was desirable because it does not 
overlap with the Eosin Y absorption spectrum. BSA-AlexaFluor 594 was chosen because 
BSA is a well-characterized molecule with known diffusion properties, and AlexaFluor 
594’s excitation/emission spectrum also does not overlap with Eosin Y. For the 
PEG/Collagen IPNs, we investigated three PEG4NB concentrations: 5 mM, 7.5 mM, and 
10 mM. Gels were formed within 24-well transwell inserts (Corning) containing a 
polyester membrane with 0.4 µm diameter pores and a pore density of 4 x 10
6
 pores per 
cm
2
. After formation of the gels, a solution containing the molecule of interest was added 
to the top of the transwell insert and allowed to diffuse into the gel. To ensure that the 
molecules had fully diffused into the gels, diffusion experiments were performed 3 and 7 
days after the addition of I-2959 and BSA-AlexaFluor 594, respectively. 
 Upon starting the diffusion experiments, 1000 µL of PBS was added to the 
bottom of the transwell plates (referred to as the bath) and the plates were put on a shaker 
to avoid boundary effects. The diffusion kinetics were measured by periodically taking 
aliquots from the PBS bath over the course of 2 and 6 hours for I-2959 and BSA-
AlexaFluor 594, respectively. The molecular concentrations in the PBS bath were then 
measured using a SpectraMax M5 Plate Reader (Molecular Devices) by absorbance at 
290 nm for I-2959 and fluorescence at 590/617 excitation/emission for BSA-AlexaFluor 
594.  
5.4.2b Results from Biomolecular Diffusion Tests 
 The diffusion kinetics of BSA and I-2959 are shown in Figure 5-17. For the BSA 
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experiments, the PEG/Collagen IPNs all displayed significantly impaired BSA diffusion 
kinetics (Figure 5-17a). However, for the I-2959 experiments, while the 7.5 mM and 10 
mM PEG/collagen IPN conditions exhibited impaired I-2959 diffusion kinetics, the 5 
mM did not as compared to the 2 mg/mL collagen control (Figure 5-17b). However, two 
of the transwell inserts in this condition appeared to be leaky, which likely caused the 
diffusion kinetics to appear faster than they otherwise would have been.  
From the diffusion curves, the diffusion coefficients within each condition can be 
calculated using the semi-infinite slab approximation
66,206
, which is governed by the 
following equation: 
𝑐𝑏𝑎𝑡ℎ = 𝑐𝑚𝑎𝑡𝑟𝑖𝑥
𝐴𝑚𝑎𝑡𝑟𝑖𝑥
𝑉𝑏𝑎𝑡ℎ
2√𝑡
𝐷𝑚𝑎𝑡𝑟𝑖𝑥
𝜋
   (5-3) 
where cbath is the concentration in the PBS bath below the transwell, cmatrix is the 
concentration within the 3D gel, Amatrix is the surface area of the gel through which flux 
occurs, Vbath is the volume of PBS below the transwell, t is time, and Dmatrix is the 
diffusion coefficient within the 3D gel. For the semi-infinite slab approximation to be 
valid, cbath and cmatrix are assumed to not significantly change over time. Importantly, 
Dmatrix can be calculated based on the slope of the linear curves of cbath-squared versus 
time. Plotting our diffusion data in this manner (Figure 5-17c-d) revealed the semi-
infinite slab approximation to be valid as the experimental data showed a good fit (R
2
 > 
0.90).  
 The semi-infinite slab approximation enabled us to calculate the diffusion 
coefficients for both BSA and I-2959 as a function of PEG concentration in the 
PEG/Collagen IPN platform (Figure 5-18). The BSA diffusion coefficient within 2 
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mg/mL collagen was found to be equal to 1.01 ± 0.19 x 10
-7
 cm
2
/s, and decreased to 7.25 
± 2.84 x 10
-9
 cm
2
/s, 3.87 ± 2.5 x 10
-9
 cm
2
/s, and 2.74 ± 1.3 x 10
-9
 cm
2
/s for 5 mM, 7.5 
mM, and 10 mM PEG4NB IPNs, respectively. In addition, a similar trend was also 
observed for the I-2959 diffusion coefficients as they were found to be equal to 6.47 ± 
0.38 x 10
-6
 cm
2
/s, 6.41 ± 1.42 x 10
-6
 cm
2
/s, 3.05 ± 0.19 x 10
-6
 cm
2
/s, and 3.09 ± 0.11 x  
10
-6
 cm
2
/s for 0 mM, 5 mM, 7.5 mM, and 10 mM PEG4NB IPNs, respectively.  
 The lower diffusion coefficients observed in the IPN conditions are consistent 
with the SEM imaging results, as the addition of the secondary PEG network appears to 
decrease the porosity of the collagen network. Importantly, these results suggest that the 
addition of the secondary PEG network could mechanically constrain cells as the pore 
size is an order of magnitude smaller than cells.  
5.4.3 Mechanical Testing of PEG/Collagen IPNs 
 The mechanical properties of PEG/Collagen IPNs were investigated because we 
hoped to control the mechanical properties of the PEG/Collagen IPN platform 
independent of collagen fiber density. Here, we chose to use the Piuma nanoindenter, as 
previously described in Section 5.3.2, because it enabled us to test the mechanical 
properties of pre-formed and fully-hydrated samples. 
5.4.3a Materials and Methods 
 The method for mechanical testing PEG/Collagen IPNs followed the same 
method outlined in Section 5.3.2. Pure 2 mg/mL collagen and PEG/Collagen IPNs with 
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PEG4NB concentrations of 5 mM, 7.5 mM, and 10 mM with the corresponding 1:2 molar 
ratio of PEGdithiol were tested.  
5.4.3b Results 
  The mechanical testing results demonstrated that reinforcing the collagen network 
with a PEG secondary network tunes the overall network elastic modulus several orders 
of magnitude: ranging from ~ 40 Pa for PEG/Collagen IPNs containing 5 mM PEG4NB 
to ~ 4,000 Pa for PEG/Collagen IPNs containing 10 mM PEG4NB, as shown in Figure 5-
19. These results are promising because it means we can tune the mechanical properties 
of our IPN platform over a large range; between the elastic moduli of normal mammary 
glands (~ 200 Pa) and cancerous breast tissue (~ 1600 Pa)
8
. 
5.4.4 Conclusions from PEG/Collagen IPN Material Characterization 
The material characterization experiments of PEG/Collagen IPNs revealed that 
adding a secondary network of thiol-ene PEG to a 3D collagen network enables the 
overall network mechanical properties to be tuned over several orders of magnitude. In 
addition, SEM imaging showed that the secondary PEG network interpenetrates the 
collagen network and generates a more homogeneous overall network. Moreover, the 
PEG network alters biomolecular transport behavior within PEG/Collagen IPNs, as 
exhibited by the BSA and I-2959 diffusion results, which are consistent with the SEM 
results. Therefore, taken together, these results suggest that the secondary PEG network, 
without incorporating MMP-degradable crosslinkers, may act as a physical barrier 
through which cells cannot invade. 
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5.5 Investigating the Cellular Response to PEG/Collagen IPNs   
 Once the PEG/Collagen IPN platform had been characterized from a material 
standpoint, we then investigated its cellular response by performing single-cell migration, 
single-cell viability, single-cell proliferation, and spheroid invasion assays of cells 
embedded within the PEG/Collagen IPNs. 
5.5.1 Experimental Setup for PEG/Collagen IPN Cell Culture 
 One of the first logistical issues encountered when trying to generate cell-laden 
PEG/collagen IPNs was laser cooling. Specifically, the medical-grade laser (Ultima 2000 
SE Argon Laser System, Lumenis) is forced air cooled, which translates into the laser 
requiring approximately 12 minutes to cool between samples. As a result of this extended 
cooling time, only one sample could be irradiated every 15 minutes, which meant that the 
addition of polymer solutions to the collagen gels needed to be staggered accordingly. 
Moreover, to prevent adjacent samples from being inadvertently exposed to laser light, 
each PEG/Collagen IPN sample was formed on a 35 mm glass-bottom dish and irradiated 
individually.  
 However, the use of 35 mm dishes raised another issue with respect to the volume 
of PEG monomer solution. In 24-well plates, as was used to test the cytocompatibility of 
the soluble PEG monomers, 300 µL of monomer solution was enough to completely 
submerge the collagen gels; but for 35 mm dishes, the required volume increased to over 
1 mL. This significant increase in required polymer solution meant that more PEG 
monomer material would be needed for every test. The issue was resolved by using 3D-
printed plastic molds to cast a micro-well out of polydimethylsiloxane (PDMS) within 
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each 35 mm glass-bottom dish, as shown in Figure 5-20. The smaller well within each 35 
mm glass-bottom dish had dimensions of 12 mm in diameter and 6 mm tall, which 
reduced the required volume of the polymer solution to 250 µL and saved monomer 
material usage by four-fold. As a result of the 3D-printed molds, cell-laden 
PEG/Collagen IPNs could be formed within a 35-mm glass-bottom dish and irradiated 
individually.  
5.5.2 PEG/Collagen IPN Single-Cell Migration Assays 
 We hypothesized that because the pore size of the secondary interpenetrating PEG 
network is on the order of nanometers, cells would be unable to migrate through 
PEG/Collagen IPNs containing non-degradable crosslinkers. Therefore, we investigated 
the migration behavior of MDA.MB.231s diffusely embedded within PEG/Collagen 
IPNs.  
5.5.2a Materials and Methods 
 PEG/Collagen IPNs with MDA.MB.231s diffusely embedded were prepared 
according to the experimental workflow as previously described in Section 5.3.4. Here, 
PEG/Collagen IPNs were formed containing 0, 5, 7.5, and 10 mM of PEG4NB with the 
corresponding 1:2 molar ratio of PEG4NB:PEGdithiol. To record single cell migration 
behavior, brightfield time-lapse images were acquired using a confocal microscope with 
an environmental chamber. Image acquisition began immediately after PEG/Collagen 
IPN crosslinking, and images were acquired every 10 min for 24 hours.  
 The time-lapse images were analyzed using a custom-written ImageJ routine in 
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combination with Imaris image analysis software. Three-dimensional bright-field images 
were z-projected using the minimum pixel intensity value from the z-stack and inverted. 
The resulting z-projected image was then imported into Imaris and the spot-tracking 
algorithm was used to track the z-projected motion of individual cells.  
5.5.2b Results 
 The single-cell migration assays showed that cells embedded within the 
PEG/Collagen IPN platform were essentially immobilized (Figure 5-21a), while cells in 
the non-irradiated control displayed no significant difference in cell speed across all 
polymer concentrations. For the irradiated PEG/Collagen IPN conditions, mean cell 
speed of the entire population was equal to 22.5 ± 0.9, 11.6 ± 0.9, 7.5 ± 0.5, and 7.7 ± 0.3 
µm/hr for the 0, 5, 7.5, and 10 mM PEG4NB, respectively (Figure 5-23b). However, the 
mean cell speeds for the non-irradiated controls were 23.9 ± 0.4, 23.7 ± 0.30, 23.7 ± 0.30, 
and 23.8 ± 0.26 µm/hr for 0, 5, 7.5, and 10 mM PEG4NB, respectively (Figure 5-23b). It 
should also be noted that cell speeds less than 15 µm/hr represent cells that are oscillating 
in place and not translocating. These results indicate that the PEG/Collagen IPNs, without 
cell-degradable crosslinkers, physically constrain cells and inhibit their migration. 
Moreover, the results from the non-irradiated controls, suggest that this lack of motion is 
due to mechanical confinement and not a chemical effect resulting from the soluble 
monomers prior to crosslinking.   
5.5.3 PEG/Collagen IPN Single-Cell Viability Assays 
In two-dimensional studies, softer substrates have been shown to inhibit cell 
spreading and promote apoptosis as compared to stiffer substrates
265
. However, in our 
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PEG/Collagen IPN platform, we hypothesized that mechanically confining cells in 3D 
could make them less viable.  
5.5.3a Materials and Methods 
To test this hypothesis, we embedded MDA.MB.231 cells with PEG/Collagen 
IPNs as described in Section 5.5.2. After 24 hours of being embedded within 
PEG/Collagen IPNs, cell viability was assessed using a LIVE/DEAD assay as mentioned 
in Section 5.2.4.  
5.5.3b Results 
 The viability results revealed that encapsulating MDA.MB.231 cells within the 
PEG/Collagen IPN platform decreased viability with increasing PEG4NB concentration 
as viabilities were found to be equal to 88.4 ± 0.4, 84.8 ± 1.7, 76.8 ± 4.0, and 74.9 ± 1.1% 
(mean ± S.D.; n = 3) for PEG/Collagen IPNs containing 0, 5, 7.5, and 10 mM PEG4NB, 
respectively (Figure 5-22a). To determine whether this decrease in viability was due to 
mechanical confinement or a chemical effect from the soluble monomers, we performed 
the control in which the monomer solutions were added to the cell-laden collagen gels, 
but not irradiated. Here, in the non-irradiated controls, the viabilities were found to be 
equal to 95.0 ± 3.2, 95.6 ± 2.3, 97.2 ± 1.96, and 97.2 ± 0.6% (mean ± S.D.; n = 3) for 
polymer solutions containing 0, 5, 7.5, and 10 mM PEG4NB, respectively (Figure 5-22a). 
Therefore, the results suggest that the decrease in viability exhibited by the crosslinked 
PEG4NB conditions is a mechanical effect and not a consequence of the soluble 
monomers prior to crosslinking.  
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In addition, the visible-light irradiated 0 mM control displayed a slight, but not 
statistically significant, decrease in viability compared to the non-irradiated 0 mM 
control. This result was further investigated by repeating the experiment for the 0 mM 
condition (Figure 5-22b), and the results of the repeated experiment showed no 
significant difference in cell viability between the irradiated and non-irradiated samples. 
Therefore, we concluded that exposure to the green laser light did not adversely affect 
cell viability. 
 The viability analysis of MDA.MB.231 cells embedded within PEG/Collagen 
IPNs supported our hypothesis that mechanically confining cells within collagen gels via 
a secondary interpenetrating PEG network negatively affects cell viability. The results 
further highlight the differences between 2D and 3D culture systems as increasing matrix 
stiffness in our 3D IPN platform actually led to decrease in cell viability, which counters 
the trend found in 2D culture systems.  
5.5.4 PEG/Collagen IPN Proliferation Assays 
 To assess the proliferation behavior of cells within the PEG/Collagen IPN 
platform, proliferation was assessed using the commercially-available Click-iT EdU 
(ThermoFisher) assay. In this assay, EdU is a nucleoside analogue that is readily 
incorporated into newly synthesized DNA during cellular proliferation. Moreover, the 
EdU assay was chosen over the traditional BrdU assay for the following reasons: the EdU 
assay 1) uses a fluorescent small molecule to detect incorporated EdU, which avoids the 
need for large antibodies as required with BrdU; 2) does not involve DNA denaturation, 
which frequently requires harsh methods such as HCl or heat treatment that can adversely 
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affect sample quality; and 3) is less time consuming. Of the aforementioned advantages, 
its use of a small molecule to detect the incorporated EdU is the most useful to our IPN 
platform because small molecules diffuse more readily into our IPN network compared to 
large antibodies.  
5.5.4a Materials and Methods 
 The Click-iT EdU AlexaFluor 647 Imaging Kit (ThermoFisher) was used to 
assess the proliferation of MDA.MB.231 cells embedded within PEG/Collagen IPNs. 
Here, cell-laden PEG/Collagen IPNs were formed as previously described in Section 
5.5.2. After forming the PEG/Collagen IPNs, the cells were cultured for 48 hours in 
normal cell culture media, at which point the cell culture media was replaced with fresh 
media containing 10 µM of EdU. Cell-laden PEG/Collagen IPNs were incubated with the 
EdU media for 16 hours and then fixed with 4% PFA. The fixed PEG/Collagen IPNs 
were then prepared for EdU staining using the manufacturer’s protocol. After staining 
with the Alexa Fluor 647 azide small molecule, the samples were counterstained with 
Hoechst 33342 for nuclear detection.  
The samples were then imaged using an Olympus FV1000 scanning confocal 
microscope, and 150 µm stacks with 3 µm image intervals were acquired. The images 
were evaluated using Imaris image analysis software (Bitplane, St. Paul, MN). Briefly, 
the total number of nuclei were identified using the spot-detection algorithm for the 
Hoechst 33342 channel, and the minimum intensity threshold was set according to an 
unstained control. Then, the number of EdU
+
 nuclei were identified using the spot-
detection algorithm for the EdU channel, and the minimum intensity threshold was set 
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according to controls that were not treated with EdU, but stained with the AlexaFluor 647 
azide molecule.  
5.5.4b Results 
 The EdU assay revealed that mechanically confining cells within the non-
degradable PEG/Collagen IPN platform significantly decreased the proliferation rate with 
the percentage of EdU
+
 cells being equal to 72.8 ± 8.3, 12.9 ± 15.0, 12.97 ± 15.4, and 3.0 
± 6.1% (mean ± S.D.; n = 3 gels, 4 locations per gel) for 0, 5, 7.5, and 10 mM PEG4NB, 
respectively (Figure 5-23a). To confirm that these results were due to mechanical effects 
and not chemical, we performed the control in which the PEG monomer solutions were 
added, but not irradiated. The percentage of EdU
+
 cells were found to be equal to 73.4 ± 
10.9, 73.9 ± 20.9, 76.2 ± 12.4, and 61.0 ± 18.9% (mean ± S.D.; n = 3 gels, 4 locations per 
gel) for 0, 5, 7.5, and 10 mM PEG4NB, respectively (Figure 5-23a). Therefore, these 
results suggest that the decrease in proliferation is due to mechanical confinement from 
the crosslinked PEG network, and not a result from the soluble monomers prior to 
crosslinking.  
 In addition, we found that mechanically confining cells with a secondary PEG 
network was more effective at inhibiting proliferation than serum-starvation (Figure 5-
23b). To this end, cells embedded within 2 mg/mL collagen gels were serum-starved 
beginning at the same time point as when the other conditions were receiving soluble 
monomer solutions. The cells were then cultured in serum-free media for 48 hours, at 
which point the media was replaced with fresh serum-free media containing 10 µM of 
EdU. The EdU assay was then performed using the previously described protocol. 
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Interestingly, serum-depletion did elicit a decrease in proliferation, 58.8 ± 11.0% (mean ± 
S.D.; n = 3 gels, 4 locations per gel), but the proliferation remained significantly higher 
than the PEG/Collagen IPN conditions indicating that mechanical confinement is more 
effective at inhibiting proliferation than the removal of growth factors.  
5.5.5 Spheroid Invasion within PEG/Collagen IPNs 
 The inhibitory effect of PEG/Collagen IPNs on single-cell migration led us to 
investigate whether this inhibitory behavior would also be present within embedded 
spheroid models. We hypothesized that adding a secondary, non-degradable PEG 
network would mechanically confine the 3D embedded spheroid model and inhibit local 
invasion into the collagen. 
5.5.5a Materials and Methods 
 MDA.MB.231 multicellular spheroids were formed as previously described in 
Section 3.2, embedded within 2 mg/mL collagen gels, and allowed to adhere for 24 
hours. PEG polymer solutions were then added and allowed to diffuse as previously 
described in Section 5.2.2. Images of the embedded spheroids were recorded by taking 
brightfield images at Day -1, 0, 1, 3, 5, and 7. 
 The average radius of the invasive edge of the spheroids were quantified using a 
custom-written MATLAB code adapted from a previously developed computational 
method
266
. First, the magnitude of the gradient of each image was taken. Second, the 
magnitude of the gradient taken along radial line vectors originating from the centroid of 
the spheroid were recorded (Figure 5-24). Third, the invasive edge of the spheroid was 
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determined for each line vector by measuring the distance from the centroid to the point 
at which the magnitude of the gradient fell to half of its maximum value; this value was 
arbitrarily chosen, but validated by visual inspection. The average radius of the invasive 
edge for each spheroid was then calculated by averaging the line vectors. In this work, 16 
line vectors were used for each spheroid.  
5.5.5b Results 
 The results revealed that adding a secondary, non-degradable PEG network did 
impair MDA.MB.231 spheroid invasion into the surrounding matrix (Figure 5-26). 
Furthermore, the non-irradiated controls displayed significant invasion indicating that this 
result was due to a mechanical effect and not a chemical effect from the soluble 
monomers prior to crosslinking (Figure 5-26). Eventually, narrow protrusions from the 
spheroid did develop within the PEG/Collagen IPN conditions, but the overall number of 
invading cells appeared to be significantly less than the control. Therefore, these results 
show that the PEG/Collagen platform, without incorporating cell-degradable crosslinkers, 
mechanically confines spheroids and inhibits their invasion.   
5.6 Discussion of Thiol-ene PEG/collagen IPNs 
 The interpenetrating network designed in this work is composed of a primary 3D 
collagen network reinforced by a secondary PEG network. This approach integrates the 
inherent bioactivity associated with native collagen networks with the tunable mechanical 
properties associated with synthetic polymeric networks. Moreover, because we designed 
our platform such that soluble monomers are first delivered to the cell-laden collagen 
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network and then crosslinked into a 3D network via visible light, this approach maintains 
the collagen network’s fibrillar architecture and allows for the effects of network 
mechanics to be studied independently of fiber density. We predict this approach will be 
applicable to other naturally-derived materials such as reconstituted basement membrane 
(i.e. Matrigel) and fibrin gels.  
 Importantly, the use of thiol-ene “click” chemistry enabled us to develop an IPN 
platform that met our initial design goals. The IPN platform described herein 1) is formed 
from small monomers capable of readily diffusing into the cell-laden collagen network, 
2) provides spatiotemporal control of crosslinking, 3) forms a stable secondary network 
upon crosslinking, and 4) has a limited effect on cell viability. Furthermore, as opposed 
to the MPC/EGDMA system, the PEG4NB/PEGdithiol system was not inhibited by 
oxygen molecules, which enables it to be used with living cells. 
 In addition, material characterization via SEM imaging, molecular transport 
experiments, and mechanical testing showed that the secondary PEG network 
interpenetrates the primary collagen network and reduces the overall network porosity. 
The decrease in network porosity, combined with the simultaneous increase in network 
stiffness, was hypothesized to act as a physical barrier through which cells could not 
invade. The advantages of this approach are two-fold: first, the effect of mechanical 
confinement, which is often present during early-stage tumors that have not yet broken 
through the basement membrane, can be studied in a controlled manner. Moreover, 
mechanical confinement is thought to exert a compressive solid stress on the growing 
tumor
267
, and compressive forces have been shown to affect cellular behavior such as 
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cancer cell migration
268
, proliferation
269
, apoptosis
269
, and in a rather interesting study, 
mesenchymal cell differentiation during embryonic tooth organ formatin
78
. Therefore, 
improving our understanding of how tumors evolve to overcome this mechanical 
confinement may be an area of research that our PEG/Collagen IPN platform may prove 
to be useful. Second, although it was not investigated in this work, the PEG network can 
be designed such that it can be degraded by cellular MMPs through the incorporation of 
MMP-degradable peptide crosslinkers. Such an approach could enable the PEG/Collagen 
IPN platform to be used to study the effects of cell-mediated network degradation on 
cellular behavior ranging from completely non-degradable networks, such as the one 
investigated in this study, to readily degradable networks. Moreover, recent studies have 
suggested that substrate stress relaxation, potentially modulated through cell-mediated 
degradation of ECM networks, has a profound effect on cytoskeletal tension and 
subsequently mechanotransductive signaling
205,270
. Therefore, our PEG/Collagen 
platform could be used to study these effects within a 3D environment.  
 Further investigation showed that the PEG/Collagen IPN reduced single-cell 
migration and impaired spheroid invasion. Moreover, the addition of PEG monomer 
solutions alone, without crosslinking via irradiation with visible light, did not adversely 
affect cellular motility. Furthermore, cells embedded within PEG/Collagen IPNs were 
significantly less proliferative than their counterparts embedded within collagen alone, 
including the serum-starved control condition, which suggests that mechanical 
confinement may be more effective at inhibiting proliferation than removal of soluble 
growth signals. Additionally, cell viability decreased with increasing PEG/Collagen IPN 
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stiffness, demonstrating that mechanical confinement may promote pro-apoptotic 
signaling pathways. 
 Another potential area for future work could be to study drug efficacy as a 
function of 3D extracellular matrix stiffness. In 2D studies, increasing substrate stiffness 
has been shown to be associated with mechano-mediated drug resistance
241
, however in 
3D studies, increasing the stiffness of alginate-Matrigel IPNs decreased resistance of 
leukemia cells to chemotherapy
271
. The opposing trends in 2D vs 3D mechano-mediated 
drug resistance could be reconciled using our IPN platform. 
 In addition to its potential in vitro applications, the approach described in this 
work raises the interesting question of whether a similar approach could be used to 
mechanically confine tumors in vivo. While increased collagen deposition and ECM 
stiffening have been shown to further promote tumor progression
3,8
, the tumor-associated 
ECM is degradable, which promotes aberrant mechanotransductive signaling and 
eventually cellular migration. However, if a non-degradable network were to be delivered 
to the periphery of a tumor, this could potentially impair both mechanotransductive 
signaling (due to a lack of cell-mediated degradation of the ECM) and migration (due to 
an order of magnitude decrease in network pore size). Such an approach would be a 
significant deviation from current cancer therapy methods, but it would target the 
physical phenomena underlying cancer progression and may provide a novel approach to 
impairing the progression of aggressive tumors. 
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a) The PEG/Collagen IPN platform consists of a primary collagen network reinforced by 
a secondary visible-light-mediated thiol-ene PEG network to yield a 3D cell culture 
system that is both inherently bioactive and mechanically tunable. The secondary PEG 
network consists of 4-armed PEG norbornene terminated monomers crosslinked with 
linear PEG dithiol monomers. To form IPNs, b) soluble monomers are first diffused into 
the collagen network and then crosslinked with Eosin Y as the photoinitiator by 
irradiating with visible light at 514 nm.  
  
Figure 5-1: Overview of PEG/Collagen IPN 
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Figure 5- 2: Schematic of MPC/EGDMA Network Chemistry 
Three-dimensional networks are formed by the free-radical polymerization reaction 
between EGDMA and MPC. The network mechanical properties can be tuned by altering 
the ratio of MPC to EGDMA as more EDGMA results in a more crosslinked network and 
thus a stiffer gel. Figure adapted from Herrick et al. (2013)
240
. 
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Figure 5- 3: Schematic of PEG4NB/PEGdithiol Network Chemistry 
 
 
  
Three-dimensional networks are formed by a step-growth radical polymerization reaction 
between PEG4NB and PEGdithiol.  
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The propagation of the thiol-ene reaction consists of alternating addition and chain 
transfer reactions. In the addition reaction, a thiyl radical adds across carbon-carbon 
double bonds to create a carbon radical. In the chain transfer reaction, the carbon radical 
abstracts a hydrogen from another thiol functional group to produce another thiyl radical, 
thus propagating the reaction. For some ene functional groups, a homo-polymerization 
reaction can occur whereby a carbon radical adds across the carbon-carbon bond of 
another ene group. However, norbornene does not homo-polymerize and the reaction 
proceeds simply by alternating addition and chain transfer reactions. Figure taken from 
Cramer et al. (2013)
254
.  
Figure 5- 4: Thiol-ene Reaction Mechanism 
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The viability of collagen-embedded MDA.MB.231 cells was assessed following 16 hrs of 
incubation with photoinitiators in the absence of light. In the control condition, in which 
MDA.MB.231 cells were incubated without photoinitiator, the viability was 98.8 ± 1.3% 
(n = 3).  a) I-2959 did not exhibit cytotoxicity at its working concentration of 0.1 wt%, 
Figure 5- 5: Viability Analysis of Photoinitiators 
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but did show a statistically significant decrease in viability at 0.8 wt%. b) LAP did not 
display a significant difference in viability at its working concentration of 0.05 wt%. c) 
Eosin Y did not show cytotoxicity at its working concentration of 0.1 mM. d) NVP, a 
comonomer for Eosin Y, did display a significant decrease in viability at its working 
concentration of 94 mM, and treatment at 470 mM and 940 mM dissolved the collagen 
gel (indicated by the #). e) TEOA, a coinitiator for Eosin Y, also displayed a statistically 
significant decrease in viability at its working concentration of 115 mM, and treatment at 
862.5 mM dissolved the collagen gel as well (indicated by the #). Data presented as mean 
± SD; n = 3. P value determined using ANOVA with Tukey-Kramer post hoc analysis 
(*P < 0.05). Asterisks indicate conditions statistically different from the untreated control.  
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Figure 5-6: Viability Analysis of MPC/EGDMA System 
The viability of collagen-embedded MDA.MB.231 cells was assessed following 16 hrs of 
incubation with either a) MPC, b) EGDMA, or c) PEGDMA (Mn = 750 D).  MPC 
exhibited the highest degree of cytocompatibility as viability did not decrease until MPC 
concentration reached above 100 mM. For EGDMA, viability decreased to 80.4 ± 3.9% 
at a concentration of 1.69 mM. For PEGDMA, the viability at 1.69 mM was found to be 
91.8 ± 2.0%, indicating that the longer PEGDMA crosslinker is not as cytotoxic as the 
shorter EGDMA crosslinker. Data presented as mean ± SD; n = 3. P value determined 
using ANOVA with Tukey-Kramer post hoc analysis (*P < 0.05). Asterisks indicate 
conditions statistically different from the untreated control.  
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The viability of collagen-embedded MDA.MB.231 cells was assessed following 16 hrs of 
incubation with either a) PEG4NB or b) PEGdithiol (MW = 3.4 kD). In all concentrations 
tested, viability was not significantly different from the untreated control. Data presented 
as mean ± SD; n = 3. P value determined using ANOVA with Tukey-Kramer post hoc 
analysis. 
  
Figure 5-7: Viability Analysis of PEG4NB/PEGdithiol System 
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r PEG4NB:PEGdithiol α 
0.25 1:8 1.15 
0.5 1:4 0.82 
0.75 3:8 0.66 
1.0 1:2 0.58 
0.75 2:3 0.66 
0.5 1:1 0.82 
0.25 1:2 1.15 
 
Table 5-1: Flory-Stockmayer Gel Point Values 
The Flory-Stockmayer equation was used to predict the gel point values for a system 
containing 4-arm PEGnorbornene and linear PEGdithiol. The calculations reveal the 1:2 
PEG4NB:PEGdithiol molar ratio as having the lowest α value, indicating that this molar 
ratio should yield a network with the highest degree of crosslinking.  
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The viability of collagen-embedded MDA.MB.231 cells was assessed following 16 hrs of 
incubation with PEGdithiol crosslinkers having molecular weights of either 0.154 kD, 1.0 
kD, or 3.4 kD. The results illustrate that lower molecular weight crosslinkers have an 
adverse effect on cell viability. 
  
Figure 5-8: Viability Analysis of PEGdithiol Crosslinker as a Function of 
Molecular Weight 
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Figure 5-9: Time Course Viability Analysis of PEGdithiol as a Function of 
Molecular Weight 
 The viability of collagen-embedded MDA.MB.231 cells was assessed as a function of 
both PEGdithiol crosslinker length and incubation time. a) 1.0 kD PEGdithiol began to 
show adverse effects on cell viability after 12 hours of incubation for PEGdithiol 
concentrations above 20 mM. b) surface plot of PEGdithiol 1.0 kD cytocompatibility as a 
function of time and concentration. c) 0.154 kD PEGdithiol exhibited reduced viability at 
incubation times as short as 4 hours. d) surface plot of PEGdithiol 0.154 kD 
cytocompatibility as a function of time and concentration.   
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The elastic modulus of PEG hydrogels formed from 10 mM PEG4NB and 20 mM 
PEGdithiol were investigated as a function of PEGdithiol crosslinker molecular weight. 
The results show that there is an inverse relationship between crosslinker length and 
hydrogel elastic modulus. Data presented as mean ± SD; n = 3 gels with 5 indentations 
per gel. P value determined using ANOVA with Tukey-Kramer post hoc analysis 
(*p<0.001). 
  
Figure 5-10: PEG Hydrogel Nanoindentation Mechanical Testing as a Function 
of Molecular Weight 
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The hydrodynamic radius as a function of number average molecular weight (Mn) was 
estimated for a) linear PEG monomers and b) 4-arm PEG monomers using data from 
Wang et al.(2010)
260
. 
  
Figure 5-11: Fitting of Mn to Experimentally Measured Hydrodynamic Radii of 
PEG Monomers 
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Monomer Rh (nm) D0 (x10
-10
 m
2
 s
-1
) Dcollagen (x10
-10
 m
2
 s
-1
) 
4-arm PEG (10 kD) 3.65 0.87 0.78 
PEGdithiol (0.154 kD)* 0.64 5.0 4.5 
PEGdithiol (1.0 kD) 1.47 2.17 1.95 
PEGdithiol (3.4 kD) 2.53 1.26 1.13 
 
Table 5- 2: Estimation of Monomer Diffusion Coefficients within 2 mg/mL Collagen 
The estimated hydrodynamic radius (Rh) was used to calculate the free diffusion 
coefficient (D0) via the Stokes-Einstein equation for each monomer at 37 
o
C in pure water. 
The diffusion coefficient in collagen (Dcollagen) was then calculated assuming a diffusion 
coefficient ratio (Dcollagen/D0) equal to 0.90 based experimental data from Ramanujan et al. 
(2002)
272
. The asterisk associated with 0.154 kD PEGdithiol indicates a poor 
experimental fit.  
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Diffusional hindrance, as measured by the diffusion coefficient ratio (D/D0), was 
experimentally measured by Ramanujan et al. (2002) using FRAP and tracer particles 
with varying hydrodynamic radii and collagen concentrations ranging from 2.4 mg/mL to 
45 mg/mL. Figure taken from Ramanujan et al. (2002)
272
. 
  
Figure 5- 12: Diffusion Coefficient Ratio (D/D0) as a Function of Collagen 
Concentration and Hydrodynamic Radius. 
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a) A finite element model was developed in COMSOL Multiphysics and b) the diffusion 
kinetics of PEG4NB (10 kD) diffusing into 2 mg/mL collagen gels was simulated. ‘d’ 
represents the depth into the collagen gel from the top surface. The PEG4NB simulation 
is shown because PEG4NB had the largest hydrodynamic radius and should therefore 
diffuse the slowest. The model results show that diffusion equilibrium is reached within 6 
hours for PEG4NB in 1 mm thick collagen gels. 
  
  
Figure 5- 13: COMSOL Multiphysics Finite Element Diffusion Model of PEG4NB 
Diffusing into 2 mg/mL Collagen Gels 
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The experimental workflow for generating PEG/Collagen IPNs consists of the following: 
1) embedding cells within 3D collagen gels 24 hours prior to adding the soluble polymer 
solution, 2) adding the soluble polymer solution and allowing 6 hours for the polymer to 
fully diffuse into the collagen gel, 3) removing excess polymer solution and irradiating 
the sample with visible light to initiate crosslinking, 4) washing the sample 3x’s with cell 
culture media to remove any uncrosslinked monomers, and 5) adding a final volume of 
cell culture media to the IPN and proceeding to perform the experiment of interest. 
 
  
Figure 5- 14: The Experimental Work Flow for Generating PEG/Collagen IPNs 
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The microstructures of a) collagen, b) PEG/Collagen IPN, and c) PEG gels were 
investigated via SEM imaging (scale bar equal to 10 µm). Histograms of pixel intensity 
for d) collagen, e) PEG/Collagen IPN, and f) PEG are also shown. The left-shifted curve 
in the histogram for the pure collagen condition reflects its highly porous microstructure, 
while the more normalized curve in the PEG/Collagen IPN histogram is indicative of the 
secondary PEG network interpenetrating the porous collagen network. In addition, the 
pure PEG condition appears as a continuous material due to its nanoporous structure. 
  
Figure 5- 15: SEM Images of 3D Networks 
 150 
The experimental set-up for characterizing biomolecular transport properties involved the 
following: 1) forming 3D gels within 24-well transwell inserts, 2) adding a solution 
containing the molecule of interest to the top of the insert, 3) allowing the molecule to 
diffuse into the 3D gel, 4) adding PBS to the bottom of the insert, and 5) taking samples 
of PBS from the bottom of the insert over the course of several hours, which were then 
analyzed using a SpectraMax plate-reader.   
  
Figure 5- 16: The Experimental Setup for Characterizing Biomolecular 
Transport 
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Figure 5- 17: The Diffusion Kinetics of BSA and I-2959 from Collagen and 
PEG/Collagen IPN Gels 
The diffusion kinetics for a) BSA-AlexaFluor 594 and b) I-2959 from 2 mg/mL collagen 
(0 mM) and PEG/Collagen IPNs composed of PEG4NB at 5 mM, 7.5 mM, and 10 mM 
are shown. The experimental diffusion data were fitted to a semi-infinite slab 
approximation and both the c) BSA and d) I-2959 diffusion experiments revealed good 
fits, indicating that the semi-infinite slab approximation is a valid method for calculating 
Dmatrix.  
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The diffusion coefficients for a) BSA-AlexaFluor 594 and b) I-2959 within 
PEG/Collagen IPNs were calculated using the semi-infinite slab approximation. Data 
presented as mean ± SD; n = 3. P value determined using ANOVA with Tukey-Kramer 
post hoc analysis (* p<0.001).  
  
Figure 5- 18: Diffusion Coefficients of BSA and I-2959 within PEG/Collagen IPNs 
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The elastic moduli of PEG/Collagen IPNs spans several orders of magnitude and is equal 
to 11.3 ± 7.6, 40.7 ± 12.3, 280.3 ± 142, and 4210 ± 1440 Pa for 0 mM, 5 mM, 7.5 mM, 
and 10 mM PEG4NB, respectively. Data presented as mean ± SD; n = 3 gels with 5 
indentations per gel. P value determined using ANOVA with Tukey-Kramer post hoc 
analysis. Asterisks indicate that each concentration is significantly different from all 
others (p < 0.05).  
  
 
 
  
Figure 5- 19: PEG/Collagen IPN Nanoindentation Mechanical Testing 
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To irradiate individual samples and save material, microwells were formed within 35 mm 
glass-bottom dishes by first inserting the a) 3D-printed mold into the glass-bottom dish 
and adding PDMS. The molds were then removed leaving behind b) microwells with 
diameters equal to 10 mm. 
 
Figure 5- 20: 3D-printed PDMS Molds 
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Figure 5- 21: MDA.MB.231 Single-Cell Migration Speed within PEG/Collagen IPNs 
The migratory behavior of MDA.MB.231 cells embedded within PEG/Collagen IPNs 
were investigated. a) Box-whisker plot of migration speed of single MDA.MB.231 cells 
embedded diffusely within PEG/Collagen IPNs over the course of 24 hours immediately 
following crosslinking of IPNs. b) The average cell speed for the entire population of 
cells within the irradiated PEG/Collagen IPNs or non-irradiated controls (mean ± SEM; n 
= 3 gels, 2 locations per gel). P value determined using ANOVA with Tukey-Kramer 
post hoc analysis (*P < 0.001). 
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The viability of MDA.MB.231 cells embedded within a) PEG/Collagen IPNs was 
assessed as a function of PEG4NB concentration. For the non-irradiated controls, 
polymer solution was added to cell-laden collagen gels and incubated for 6 hours in the 
absence of light. Following the 6 hour incubation, the polymer solution was removed by 
washing 3x’s with cell culture media (45 minutes between washes). The irradiated 
conditions represent the viability of MDA.MB.231 cells embedded within crosslinked 
PEG/Collagen IPNs. b) The experiment assessing the viability of MDA.MB.231 cells 
embedded within 2 mg/mL collagen with and without exposure to laser light was 
repeated. The results from the repeated experiment confirm that laser light exposure does 
not elicit cell death. Data presented as mean ± SD; n = 3. P value determined using 
ANOVA with Tukey-Kramer post hoc analysis (*P < 0.05). 
  
Figure 5- 22: Viability Analysis of MDA.MB.231 Cells Embedded within 
PEG/Collagen IPNs 
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The proliferation of MDA.MB.231 cells embedded within a) PEG/Collagen IPNs was 
assessed as a function of PEG4NB concentration. For the non-irradiated controls, the 
percentage of cells positive for the proliferation marker EdU were not significantly 
different from the no polymer control. However, crosslinked IPNs formed following 
irradiation with visible light exhibited significant decreases in proliferation. Moreover, b) 
the effect of serum-depletion on MDA.MB.231 proliferation was compared to 
PEG/Collagen IPNs. Data presented as mean ± S.E.M.; n = 3 gels, 4 locations per gel. P 
value determined using ANOVA with Tukey-Kramer post hoc analysis (*P < 0.05). 
  
Figure 5- 23: Proliferation Analysis of MDA.MB.231 Cells Embedded within 
PEG/Collagen IPNs 
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The invasive radii of spheroids were measured using a custom-written MATLAB code 
adapted from a previously published technique
266
. Briefly, a) the centroid of a given 
spheroid was identified and radial line vectors originating from the centroid were 
determined. b) The magnitude of the gradient for the image was calculated and resulting 
pixel values were recorded along each radial line vector. The radius of invasion was 
determined for each line vector by measuring the distance from the centroid to the point 
at which the magnitude of the gradient of the image was half of its maximum; the 0.5 
threshold was arbitrary, but selected based on visual inspection.  c) The average radius of 
invasion for a given spheroid was calculated by averaging the radius of invasion of each 
line vector.  
  
Figure 5- 24: Method for Detecting Invasive Radii of Spheroids 
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Figure 5- 25: The Average Invasive Radius of MDA.MB.231 Spheroids Embedded 
within PEG/Collagen IPNs 
The average invasive radius of MDA.MB.231 multicellular spheroids embedded within 
PEG/Collagen IPNs were measured as a function of time. The addition of PEG monomer 
solution to the embedded spheroids did not alter their invasive behavior, as shown by the 
non-irradiated controls (dash lines). However, the addition of a secondary 
interpenetrating PEG network to the collagen gel significantly impaired invasion (solid 
lines).   
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CHAPTER 6. Conclusions 
 The motivation for this work was to understand how the tumor microenvironment 
contributes to cancer progression, and to that end, this thesis rests on three 
complementary aims. In the first aim, we investigated the role of multicellular 
architecture in cancer progression by quantifying the CSC content before and after 
treatment with chemotherapy as a function of three in vitro tumor models with varying 
cellular architectures. In the second aim, we examined how the tumor microenvironment 
affects intracellular signaling by developing and experimentally validating a 
mathematical model of YAP/TAZ signaling. Finally, in the third aim, we sought to 
interrogate the effect of the 3D tumor microenvironment mechanical properties on cancer 
cell behavior, and developed a novel 3D in vitro cell culture platform consisting of an 
interpenetrating network containing PEG and collagen. With these aims, we developed a 
suite of in vitro tools that enabled us to probe how multicellular architecture, intracellular 
signaling, and extracellular matrix mechanics contribute to cancer progression.  
6.1 Investigating CSC Response to Chemotherapeutic Treatment as a Function 
of In Vitro Tumor Model 
6.1.1 Scientific Contributions 
 With respect to Specific Aim 1, this work quantified the CSC content within three 
in vitro spheroid models: a 1) 2D monolayer, which geometrically constrains the cells 
and imparts a forced polarity, a 2) 3D diffuse model, which mimics critical cell-ECM 
interactions, but not necessarily cell-cell interactions, and a 3) 3D in vitro collagen-
embedded spheroid model, which recapitulates cell-cell and cell-ECM interactions. The 
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CSC content was found to be enriched within the 3D spheroid model, as evidenced by 
three independent approaches: the ALDEFLUOR assay, mammosphere assay, and 
TaqMan RT-qPCR gene expression assay.  Furthermore, isolating the spheroid periphery 
population from the spheroid core population revealed the CSC content to have a spatial-
dependence. Therefore, these findings suggest that the aberrant multicellular architecture, 
a key characteristic of in vivo tumors, may enrich for the CSC phenotype. 
 In addition, we found that while paclitaxel treatment enriched for CSC-related 
genes across all in vitro models, cisplatin treatment revealed a context-dependent result. 
Here, cisplatin treatment led to the enrichment of CSC-related genes in the 2D monolayer 
and 3D diffuse tumor models, but not the 3D embedded spheroid model. We 
hypothesized that the lack of an observed enrichment of CSC-related genes within the 
spheroid model was due to a lower overall proliferation rate within the spheroid model 
compared to the 2D monolayer and 3D diffuse conditions. Immunofluorescent imaging of 
the proliferation marker Ki67 supported our hypothesis as the proliferation rate within the 
spheroid model was significantly lower than in the 2D monolayer and 3D diffuse models.  
 The findings from Specific Aim 1 highlight the need to screen for CSC-specific 
drugs within in vivo-relevant microenvironments as we found that the CSC response to 
cisplatin was context-dependent.  
6.1.2 Future Investigations 
 The investigations described in Specific Aim 1 utilized monocultures, however 
stromal cells in the tumor microenvironment have also been shown to promote tumor 
progression. Therefore, one potential direction of future work could be to investigate the 
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effect of stromal cells (such as fibroblasts, monocytes or endothelial cells) on CSC 
behavior within the embedded spheroid model.  
 In addition, the microenvironmental properties unique to the multicellular 
spheroid model could be explored with respect to CSC content. For example, future 
investigations could focus on cell-cell signaling pathways such as Notch, which have 
previously been shown to mediate normal stem cell behavior. Furthermore, the effect of 
intercellular forces present within the spheroid model on CSC content could also be 
explored. Recently, Rho-signaling-directed YAP/TAZ activity has been shown to be 
integral to the survival and expansion of embryonic stem cells (ESCs) when cultured as 
aggregates
120
. Interestingly, this result was context-dependent, and upregulation of 
YAP/TAZ activity within ESCs cultured as single-cells led to apoptosis. Therefore, 
future work could use our 3D in vitro spheroid model to investigate whether a similar 
context-dependent YAP/TAZ signaling pathway exists in CSCs.  
 Future work could also improve upon the limitations of this study. For example, 
CSC content in response chemotherapeutic treatment was assessed using TaqMan RT-
qPCR of CSC-related genes because the TaqMan assay is highly sensitive. However, 
while this approach revealed changes in expression of CSC-related genes at the 
population level, it did not directly measure the number of CSCs following chemotherapy 
treatment. Therefore, future work could utilize single-cell RT-qPCR to measure the 
expression of CSC-related genes at the single-cell level. In addition, the CSC response to 
chemotherapy was assessed within immortalized breast cancer cell lines, but future work 
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could use primary cells taken from breast cancer patients, which may better reflect in vivo 
cellular heterogeneity. 
6.2 Development and Experimental Validation of YAP/TAZ Mathematical 
Model 
6.2.1 Scientific Contributions 
 In Specific Aim 2, we developed and experimentally validated a mathematical 
model of YAP/TAZ signaling , which is a pathway shown to be critical in transducing 
extracellular mechanical signals into biochemical signals for directed cellular behavior. 
Importantly, our model integrated two signaling pathways: 1) cell-ECM mechanosensing 
and 2) cell-cell contact sensing. In the non-cancerous cell line MCF10A, the model 
captured the inverse relationship between cell density and YAP/TAZ nuclear localization 
as well as the linear relationship between substrate stiffness and YAP/TAZ nuclear 
localization.  
Furthermore, by investigating the breast cancer cell line MDA.MB.231, we found 
that the downregulation of cell-cell contact sensing with a concomitant upregulation of 
cell-ECM mechanosensing yielded a synergistic relationship in localizing YAP/TAZ to 
the nucleus.  
6.2.2 Future Investigations 
 As the transcription factors YAP and TAZ have been shown to interact with a 
number of other transcription factors (e.g. the TEAD family of transcription factors), this 
model could be applied to investigate YAP/TAZ signaling within the context of other 
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signaling inputs, such as TGF-β signaling. TGF-β may be of interest because it has 
previously been shown to induce a malignant phenotype in normal epithelial cells, but 
this induction is dependent on substrate stiffness
22
. In addition, YAP/TAZ have also been 
shown to direct TGF-β-induced tumorigenic phenotypes in breast cancer23. Therefore, 
expanding our model to include both YAP/TAZ cell-ECM mechanosensing and TGF-β 
signaling pathways could provide insight into the molecular mechanisms underlying the 
relationship between ECM stiffness and TGF-β and their potential synergistic effect on 
cancer progression. 
 In addition, the mathematical model was developed and experimentally validated 
for a 2D cell culture system, which may not entirely recapitulate the in vivo 3D tumor 
microenvironment. Therefore, future work could expand the model to 3D and 
experimentally validate it with the 3D in vitro embedded spheroid model described in 
Aim 1. Importantly, many of the 3D imaging techniques used in Aim 1 (e.g. Ki67 
immunofluorescent staining) could be adapted to image YAP/TAZ localization, and such 
an approach would enable us to investigate YAP/TAZ signaling within an in vivo-
relevant 3D tumor model.   
 Finally, the mathematical model developed in this work could also be applied to 
investigate potential molecular targets for therapy. Here, our model could be used to 
identify proteins that are critical in regulating YAP/TAZ activity, and cross-reference 
them with known druggable proteins. Such an approach could lead to treatment strategies 
that may in turn lead to improved clinical outcomes.  
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6.3 Interpenetrating Network of PEG and Collagen 
6.3.1 Scientific Contributions 
 The PEG/Collagen IPN developed in Specific Aim 3 provides a 3D in vitro cell 
culture platform that is both highly tunable and inherently bioactive. Furthermore, the 
overall network mechanical properties can be decoupled from collagen fiber density, 
making it a useful platform for studying 3D mechanotransduction. Importantly, our novel 
approach of delivering PEG monomers to cell-laden 3D collagen gels and crosslinking in 
situ ensures that the collagen microstructure remains intact.  
 We characterized the cytocompatibility of a number of chemical compounds 
including: the photoinitiators (e.g. I-2959, LAP, Eosin Y), the co-initiator (TEOA), the 
comonomer (NVP), the PEG monomers (PEG4NB, PEGdithiol, EGDMA, PEGDMA), 
and MPC. Furthermore, we also investigated the effect of PEGdithiol crosslinker length 
on cell viability and found a linear relationship between crosslinker length and cell 
viability (i.e. longer crosslinkers are more cytocompatible). These cytocompatibility 
studies may provide insight into designing better degradable materials as shorter 
degradation products may elicit a cytotoxic response.  
 In addition, this work found that mechanically confining cells within a 3D non-
degradable elastic network impaired malignant cell behavior as demonstrated by 
decreased viability, proliferation, and migration/invasion. Notably, mechanically 
confining MDA.MB.231 cells within our IPN system was more effective at inhibiting 
proliferation than serum starvation. The results from this work contrast 2D findings, 
which have shown that increasing substrate stiffness leads to increases in viability, 
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proliferation, and migration. Therefore, this work demonstrates that tumor-associated 
ECM stiffening alone may not account for increased malignancy, but that ECM 
degradation may also be a key contributor.  
6.3.2 Future Investigations 
 The PEG/Collagen IPN described herein is a 3D in vitro cell culture platform that 
can be used to investigate a number of outstanding questions related to 
mechanotransduction in 3D. For example, it could be used to investigate the effect of 
solid stress on tumor progression. Solid stress is thought to accumulate as tumors grow 
and exert forces on their surrounding tissue, and it has been hypothesized that this solid 
stress initially inhibits tumor progression. However, malignant cancers somehow acquire 
the ability to overcome this solid stress and invade into the surrounding tissue. Therefore, 
our platform could be used to investigate how solid stress, resulting from mechanical 
confinement, affects cellular behavior. 
 In addition, our system could also incorporate cell-degradable crosslinkers to 
investigate how matrix degradability affects cell behavior. Such an approach could be 
used to decouple the effects of matrix stiffening and degradation on cancer progression. 
Furthermore, our system could be extended to investigate mechano-mediated drug 
resistance in 3D, which could provide a more clinically-relevant understanding.  
 The IPN platform could also be applied to study CSC behavior and/or YAP/TAZ 
signaling as a function of ECM stiffness and degradability. However, one limitation of 
the IPN is that viable cells cannot currently be extracted from the IPN platform, which 
precludes it from being used with a flow cytometry assay such as ALDEFLUOR. 
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Nonetheless, RNA has previously been extracted from similar PEG hydrogels
273
 so RT-
qPCR analysis of genes related to CSCs and/or YAP/TAZ signaling could still be 
performed.  
 Finally, our novel approach of delivering PEG monomers to cell-laden collagen 
gels and crosslinking in situ raises the question of whether a similar approach could be 
developed to encapsulate and mechanically confine in vivo tumors. Several technical 
challenges would need to be addressed, such as developing mechanisms for in vivo 
delivery and chemical crosslinking, in order for this work to become a therapy. However, 
such an approach would target the physical phenomena underlying tumor progression and 
could be used in combination with current chemotherapies to stabilize aggressive cancers. 
Therefore, while such a mechanics-based approach to cancer therapy is still far from 
being a clinically-relevant therapy, the findings in this work demonstrate that it is worthy 
of further investigation.    
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APPENDIX 
Protocol: Embedding Cancer Spheroids within 3D Collagen Gels 
Reagents: 
 1X PBS 
 Collagen Neutralizing Solution (100 mM HEPES in 2X PBS, pH 7.3) 
 Agarose (Sigma-Aldrich) 
 Sterile 96-well Microplates (Corning, cat. no. 07-200-656) 
 High Concentration Rat Tail Type I Collagen (Corning, cat. no. CB354249) 
 
Equipment: 
 50 mL beaker 
 Microwave 
 Hot Plate 
 Centrifuge  
 Pipetman 
 Pipette Tips 
 Inverted Light Microscope 
 Incubator 
 Ice Bucket 
 
Procedure: 
Preparation of agarose-coated plates for spheroid formation: 
1. Make 1.5% (wt/vol) of agarose solution by combining 0.15 g agarose with 10 mL 
of 1X PBS in a 50 mL glass beaker. 
2. Microwave the solution until the agarose is fully dissolved (~30 s). 
CRITICAL STEP: Brief boiling of the agarose is okay, but extended periods of 
boiling concentrates the agarose and impairs spheroid formation. 
3. To prevent premature agarose gelation, place the beaker of dissolved agarose 
solution on a hot plate in a biosafety cabinet and be sure that the agarose is not 
boiling on the hot plate.  
4. Prepare the agarose-coated 96-well plate by adding 70 uL of hot agarose solution 
to each well and allowing to cool for 40 minutes. 
CRITICAL STEP: To improve the uniformity of the agarose-coated wells, swirl 
the pipette tip immediately after adding the agarose solution. The goal is to obtain 
a symmetrically concave agarose coating.  
Formation of breast cancer spheroids on agarose-coated plates: 
5. Detach cell monolayers from their culture flasks using a standard trypsinization 
protocol. 
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6. Count and re-suspend in cell culture media to the desired concentration.  
7. Add 100 uL of the cell suspension to each agarose-coated well. 
8. Centrifuge the plate at 200 x g for 1 minute to improve cell aggregation at the 
bottom of the agarose-coated wells. 
9. Culture the plate for 72 hours under standard cell culture conditions.  
Preparation of collagen solution: 
10. Collagen gels are formed by combining High Concentration Rat Tail Type I 
Collagen with the collagen neutralizing solution (100 mM HEPES in 2X PBS, pH 
7.3) in a 1:1 volumetric ratio. This mixture is diluted with 1X PBS to the 
experimental collagen concentration. 
CRITICAL STEP: For better collagen gel uniformity, it is best to mix the PBS 
and collagen neutralizing solution first, and then add the more viscous collagen 
solution after. Pipette the collagen solution several times and make sure to avoid 
the introduction of air bubbles.  
11. Place the collagen solution on ice until ready to use.   
 
Embedding of breast cancer spheroids within 3D collagen gels: 
12. To ensure that only well-formed spheroids are transferred, first check the 
spheroids under a light microscope and make note of any poorly-formed 
spheroids.  
13. Transfer the spheroids to a new 96-well plate by pipette. 
CRITICAL STEP: Efficient spheroid transfer can be achieved by pipetting 10 uL 
of media along with the spheroid. The 10 uL of media should be taken into 
account when calculating the collagen gel concentrations.  
14. Place the culture plate on ice so that the collagen does not prematurely gel while 
collagen is added to the transferred spheroids.  
CRITICAL STEP: Filling a Styrofoam container with ice and wrapping it in 
aluminum foil works well. It should be sprayed with 70% ethanol and placed in a 
biosafety cabinet. 
15. Add 90 uL of collagen solution to the 10 uL of media containing the spheroid and 
swirl the pipette tip to ensure mixing of the collagen and spheroid.  
CRITICAL STEP: DO NOT pipette up and down to mix the spheroid and 
collagen. The high viscosity of the collagen solution may cause pipetting to shear 
the spheroid. 
16. Place the plate containing the embedded spheroids in an incubator and allow to 
polymerize at 37 
o
C for 1 hour. 
CRITICAL STEP: To avoid the spheroids from settling to the bottom of the plate, 
invert the plate every 2 minutes for the first 10 minutes. 
17. Add 200 uL of cell culture to media to the wells and continue culturing under 
standard cell culture conditions.  
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Timing: 
The time required for preparing the agarose-coated plates is about 30 minutes 
followed by 40 minutes of cooling. To improve timing, cell harvesting and counting can 
be performed while the agarose-coated plates cool. Therefore, the protocol for making 
spheroids on agarose-coated plates takes about 1.5 hours.  
The manual transferring of spheroids from the agarose-coated plate to the culture 
plate is the most time consuming step, however, an experienced investigator can transfer 
a full 96-well plate of spheroids in about an hour. Once the spheroids are transferred, the 
addition of collagen takes approximately 15 additional minutes. Thus, the whole spheroid 
embedding process, including the time required for collagen gelation, takes about 2.5 
hours.  
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